Ras	B-protein
-dependent	O
,	O
Ca2+-stimulated	O
activation	O
of	O
nuclear	B-protein
factor	I-protein
of	I-protein
activated	I-protein
T	I-protein
cells	I-protein
by	O
a	O
constitutively	O
active	O
Cbl	B-protein
mutant	I-protein
in	O
T	B-cell_type
cells	I-cell_type
.	O

T	B-protein
cell	I-protein
receptor	I-protein
(	O
TCR	B-protein
)	O
stimulation	O
induces	O
rapid	O
tyrosine	O
phosphorylation	O
of	O
cellular	B-protein
proteins	I-protein
,	O
including	O
Cbl	B-protein
,	O
a	O
protooncogene	B-protein
product	I-protein
whose	O
function	O
remains	O
unclear	O
.	O

As	O
a	O
first	O
step	O
toward	O
elucidating	O
the	O
function	O
of	O
Cbl	B-protein
in	O
TCR	B-protein
-initiated	O
signaling	O
,	O
we	O
evaluated	O
the	O
ability	O
of	O
wild-type	B-protein
Cbl	I-protein
or	O
a	O
transforming	O
Cbl	B-protein
mutant	I-protein
(	O
70Z/3	O
)	O
to	O
induce	O
transcriptional	O
activation	O
of	O
a	O
nuclear	B-DNA
factor	I-DNA
of	I-DNA
activated	I-DNA
T	I-DNA
cells	I-DNA
(	I-DNA
NFAT	I-DNA
)	I-DNA
element	I-DNA
derived	O
from	O
the	O
interleukin	B-DNA
2	I-DNA
(	I-DNA
IL2	I-DNA
)	I-DNA
promoter	I-DNA
in	O
transiently	O
cotransfected	O
Jurkat-TAg	B-cell_line
T	I-cell_line
cells	I-cell_line
.	O

70Z/3	B-protein
,	O
but	O
not	O
Cbl	B-protein
,	O
caused	O
NFAT	B-protein
activation	O
which	O
was	O
significantly	O
enhanced	O
by	O
stimulation	O
with	O
calcium	O
ionophore	O
,	O
and	O
was	O
drastically	O
reduced	O
by	O
cyclosporin	O
A	O
pretreatment	O
.	O

A	O
point	O
mutation	O
of	O
a	O
potential	O
phosphatidylinositol	B-DNA
3-kinase	I-DNA
(	I-DNA
PI3-K	I-DNA
)	I-DNA
binding	I-DNA
site	I-DNA
(	O
Y731EAM	B-DNA
to	O
Y731EAC	B-DNA
)	O
in	O
70Z/3	B-protein
disrupted	O
the	O
association	O
of	O
PI3-K	B-protein
with	O
70Z/3	B-protein
,	O
but	O
did	O
not	O
reduce	O
the	O
induction	O
of	O
NFAT	B-protein
activity	O
,	O
suggesting	O
that	O
the	O
interaction	O
between	O
Cbl	B-protein
and	O
PI3-K	B-protein
is	O
not	O
required	O
in	O
the	O
70Z/3	B-protein
-mediated	O
induction	O
of	O
NFAT	B-protein
.	O

Additional	O
mapping	O
studies	O
indicated	O
that	O
defined	O
deletions	O
of	O
C-terminal	O
70Z/3	B-protein
sequences	O
affected	O
to	O
a	O
variable	O
degree	O
its	O
ability	O
to	O
stimulate	O
NFAT	B-protein
activity	O
.	O

Strikingly	O
,	O
deletion	O
of	O
346	B-protein
C-terminal	I-protein
residues	I-protein
augmented	O
this	O
activity	O
,	O
whereas	O
removal	O
of	O
20	O
additional	O
residues	O
abolished	O
it	O
.	O

Coexpression	O
of	O
dominant	B-protein
negative	I-protein
Ras	I-protein
abrogated	O
the	O
basal	O
or	O
ionomycin-stimulated	O
,	O
70Z/3	B-protein
-mediated	O
NFAT	B-protein
activation	O
,	O
suggesting	O
a	O
functional	B-protein
Ras	I-protein
is	O
required	O
for	O
this	O
activation	O
.	O

These	O
results	O
implicate	O
Cbl	B-protein
in	O
Ras	B-protein
-dependent	O
signaling	O
pathways	O
which	O
lead	O
to	O
NFAT	B-protein
activation	O
.	O

THE	NULL
JOURNAL	NULL
or	NULL
BIOLOGICAL	NULL
CHEMISTRY	NULL
©	NULL
1997	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
for	NULL
Biochemistry	NULL
and	NULL
Molecular	NULL
Biology	NULL
,	NULL
Inc.	NULL
Vol	NULL
.	NULL

272	NULL
,	NULL
No	NULL
.	NULL

1	NULL
,	NULL
Issue	NULL
of	NULL
Janusry	NULL
3	NULL
,	NULL
pp	NULL
.	NULL

168-173	NULL
,	NULL
1997	NULL
Printed	NULL
in	NULL
U.S.A.	NULL
Ras-dependent	NULL
,	NULL
Ca**-stimulated	NULL
Activation	NULL
of	NULL
Nuclear	NULL
Factor	NULL
of	NULL
Activated	NULL
T	NULL
Cells	NULL
by	NULL
a	NULL
Constitutively	NULL
Active	NULL
Cbl	NULL
Mutant	NULL
in	NULL
T	NULL
Cells*	NULL
(	NULL
Received	NULL
for	NULL
publication	NULL
,	NULL
July	NULL
9	NULL
,	NULL
1996	NULL
,	NULL
and	NULL
in	NULL
revised	NULL
form	NULL
,	NULL
October	NULL
2	NULL
,	NULL
1996	NULL
)	NULL
Yun-Cai	NULL
Liu	NULL
,	NULL
Chris	NULL
Elly	NULL
,	NULL
Wallace	NULL
Y.	NULL
Langdon	NULL
}	NULL
,	NULL
and	NULL
Amnon	NULL
Altman§	NULL
From	NULL
the	NULL
Division	NULL
of	NULL
Cell	NULL
Biology	NULL
,	NULL
La	NULL
Jolla	NULL
Institute	NULL
for	NULL
Allergy	NULL
and	NULL
Immunology	NULL
,	NULL
San	NULL
Diego	NULL
,	NULL
California	NULL
92121	NULL
and	NULL
{	NULL
Department	NULL
of	NULL
Pathology	NULL
,	NULL
University	NULL
of	NULL
Western	NULL
Australia	NULL
,	NULL
Nedlands	NULL
,	NULL
West	NULL
Australia	NULL
6009	NULL
,	NULL
Australia	NULL
T	NULL
cell	NULL
receptor	NULL
(	NULL
TCR	NULL
)	NULL
stimulation	NULL
induces	NULL
rapid	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
cellular	NULL
proteins	NULL
,	NULL
including	NULL
Cbl	NULL
,	NULL
a	NULL
protooncogene	NULL
product	NULL
whose	NULL
function	NULL
remains	NULL
unclear	NULL
.	NULL

As	NULL
a	NULL
first	NULL
step	NULL
toward	NULL
elucidating	NULL
the	NULL
function	NULL
of	NULL
Cbl	NULL
in	NULL
TCR-initiated	NULL
signaling	NULL
,	NULL
we	NULL
evaluated	NULL
the	NULL
ability	NULL
of	NULL
wild-type	NULL
Cbl	NULL
or	NULL
a	NULL
transforming	NULL
Cbl	NULL
mutant	NULL
(	NULL
702/83	NULL
)	NULL
to	NULL
induce	NULL
transcriptional	NULL
activation	NULL
of	NULL
a	NULL
nuclear	NULL
factor	NULL
of	NULL
activated	NULL
T	NULL
cells	NULL
(	NULL
NFAT	NULL
)	NULL
element	NULL
derived	NULL
from	NULL
the	NULL
interleukin	NULL
2	NULL
(	NULL
L2	NULL
)	NULL
promoter	NULL
in	NULL
transiently	NULL
cotransfected	NULL
Jurkat-TAg	NULL
T	NULL
cells	NULL
.	NULL

702/3	NULL
,	NULL
but	NULL
not	NULL
Chl	NULL
,	NULL
caused	NULL
NFAT	NULL
activation	NULL
which	NULL
was	NULL
significantly	NULL
enhanced	NULL
by	NULL
stimulation	NULL
with	NULL
calcium	NULL
ionophore	NULL
,	NULL
and	NULL
was	NULL
drastically	NULL
reduced	NULL
by	NULL
cyclosporin	NULL
A	NULL
pretreatment	NULL
.	NULL

A	NULL
point	NULL
mutation	NULL
of	NULL
a	NULL
potential	NULL
phosphatidylinositol	NULL
3-kinase	NULL
(	NULL
PI3-K	NULL
)	NULL
binding	NULL
site	NULL
(	NULL
Y	NULL
``	NULL
*	NULL
``	NULL
*EAM	NULL
to	NULL
Y	NULL
``	NULL
**EAC	NULL
)	NULL
in	NULL
70	NULL
%	NULL
/3	NULL
disrupted	NULL
the	NULL
association	NULL
of	NULL
PI3-K	NULL
with	NULL
702/83	NULL
,	NULL
but	NULL
did	NULL
not	NULL
reduce	NULL
the	NULL
induction	NULL
of	NULL
NFAT	NULL
activity	NULL
,	NULL
suggesting	NULL
that	NULL
the	NULL
interaction	NULL
between	NULL
Chl	NULL
and	NULL
PI3-K	NULL
is	NULL
not	NULL
required	NULL
in	NULL
the	NULL
70	NULL
%	NULL
/3-mediated	NULL
induction	NULL
of	NULL
NFAT	NULL
.	NULL

Additional	NULL
mapping	NULL
studies	NULL
indicated	NULL
that	NULL
defined	NULL
deletions	NULL
of	NULL
C-terminal	NULL
702/83	NULL
sequences	NULL
affected	NULL
to	NULL
a	NULL
variable	NULL
degree	NULL
its	NULL
ability	NULL
to	NULL
stimulate	NULL
NFAT	NULL
activity	NULL
.	NULL

Strikingly	NULL
,	NULL
deletion	NULL
of	NULL
346	NULL
C-terminal	NULL
residues	NULL
augmented	NULL
this	NULL
activity	NULL
,	NULL
whereas	NULL
removal	NULL
of	NULL
20	NULL
additional	NULL
residues	NULL
abolished	NULL
it	NULL
.	NULL

Coexpres-sion	NULL
of	NULL
dominant	NULL
negative	NULL
Ras	NULL
abrogated	NULL
the	NULL
basal	NULL
or	NULL
ionomycin-stimulated	NULL
,	NULL
702/3-mediated	NULL
NFAT	NULL
activation	NULL
,	NULL
suggesting	NULL
a	NULL
functional	NULL
Ras	NULL
is	NULL
required	NULL
for	NULL
this	NULL
activation	NULL
.	NULL

These	NULL
results	NULL
implicate	NULL
Chl	NULL
in	NULL
Ras-dependent	NULL
signaling	NULL
pathways	NULL
which	NULL
lead	NULL
to	NULL
NFAT	NULL
activation	NULL
.	NULL

The	NULL
c-cbl	NULL
protooncogene	NULL
is	NULL
the	NULL
cellular	NULL
homologue	NULL
of	NULL
v-cbi	NULL
,	NULL
a	NULL
transforming	NULL
gene	NULL
of	NULL
the	NULL
Cas	NULL
NS-1	NULL
retrovirus	NULL
.	NULL

The	NULL
v-cbi	NULL
oncogene	NULL
was	NULL
generated	NULL
as	NULL
a	NULL
result	NULL
of	NULL
a	NULL
rearrangement	NULL
between	NULL
Cas-Br-M	NULL
virus	NULL
and	NULL
a	NULL
sequence	NULL
encoding	NULL
the	NULL
355	NULL
N-terminal	NULL
residues	NULL
of	NULL
the	NULL
c-cbl	NULL
product	NULL
.	NULL

This	NULL
oncogene	NULL
induces	NULL
pro-B	NULL
cell	NULL
lymphomas	NULL
and	NULL
myeloid	NULL
leukemias	NULL
in	NULL
mice	NULL
(	NULL
1	NULL
)	NULL
.	NULL

The	NULL
120-kDa	NULL
product	NULL
of	NULL
c-cbl	NULL
consists	NULL
of	NULL
a	NULL
highly	NULL
basic	NULL
N-terminal	NULL
region	NULL
,	NULL
a	NULL
zinc	NULL
Ring	NULL
finger	NULL
,	NULL
multiple	NULL
proline-rich	NULL
sequences	NULL
,	NULL
and	NULL
several	NULL
potential	NULL
tyrosine	NULL
phosphorylation	NULL
sites	NULL
(	NULL
2	NULL
)	NULL
.	NULL

While	NULL
the	NULL
transforming	NULL
v-cbl	NULL
product	NULL
can	NULL
be	NULL
detected	NULL
both	NULL
in	NULL
the	NULL
cytoplasm	NULL
and	NULL
the	NULL
nucleus	NULL
,	NULL
c-Cbl	NULL
is	NULL
exclusively	NULL
cytosolic	NULL
and	NULL
lacks	NULL
transforming	NULL
activity	NULL
(	NULL
3	NULL
)	NULL
.	NULL

Another	NULL
c-cbl	NULL
mutant	NULL
isolated	NULL
from	NULL
the	NULL
murine	NULL
70/3	NULL
pre-B	NULL
cell	NULL
lymphoma	NULL
encodes	NULL
a	NULL
protein	NULL
with	NULL
an	NULL
internal	NULL
deletion	NULL
of	NULL
17	NULL
amino	NULL
acids	NULL
near	NULL
the	NULL
zinc	NULL
Ring	NULL
finger	NULL
.	NULL

*	NULL
This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
United	NULL
States	NULL
Department	NULL
of	NULL
Health	NULL
and	NULL
Human	NULL
Services	NULL
Grants	NULL
CA85299	NULL
and	NULL
GM50819	NULL
.	NULL

The	NULL
costs	NULL
of	NULL
publication	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
the	NULL
payment	NULL
of	NULL
page	NULL
charges	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
advertisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

Section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

§	NULL
To	NULL
whom	NULL
correspondence	NULL
should	NULL
be	NULL
addressed	NULL
:	NULL
Division	NULL
of	NULL
Cell	NULL
Biology	NULL
,	NULL
La	NULL
Jolla	NULL
Institute	NULL
for	NULL
Allergy	NULL
and	NULL
Immunology	NULL
,	NULL
10855	NULL
Science	NULL
Center	NULL
Drive	NULL
,	NULL
San	NULL
Diego	NULL
,	NULL
CA	NULL
92121	NULL
.	NULL

Tel	NULL
.	NULL

:	NULL
619-558-8500	NULL
;	NULL
Fax	NULL
:	NULL
619-558-3526	NULL
;	NULL
E-mail	NULL
:	NULL
amnon	NULL
@	NULL
liai.org	NULL
.	NULL

This	NULL
mutation	NULL
(	NULL
702/83	NULL
)	NULL
also	NULL
activates	NULL
the	NULL
transforming	NULL
potential	NULL
of	NULL
c-cbl	NULL
,	NULL
and	NULL
the	NULL
corresponding	NULL
protein	NULL
displays	NULL
enhanced	NULL
tyrosine	NULL
phosphorylation	NULL
(	NULL
4	NULL
)	NULL
.	NULL

Several	NULL
recent	NULL
findings	NULL
support	NULL
the	NULL
notion	NULL
that	NULL
Cbl	NULL
is	NULL
involved	NULL
in	NULL
signal	NULL
transduction	NULL
pathways	NULL
:	NULL
first	NULL
,	NULL
the	NULL
proline-rich	NULL
domain	NULL
of	NULL
Cbl	NULL
mediates	NULL
constitutive	NULL
associations	NULL
with	NULL
SH3	NULL
domains	NULL
of	NULL
adaptor	NULL
signaling	NULL
proteins	NULL
,	NULL
i.e	NULL
.	NULL

,	NULL
Grb2	NULL
(	NULL
5-8	NULL
)	NULL
and	NULL
Neck	NULL
(	NULL
9	NULL
)	NULL
;	NULL
second	NULL
,	NULL
engagement	NULL
of	NULL
different	NULL
receptors	NULL
,	NULL
including	NULL
the	NULL
epidermal	NULL
growth	NULL
factor	NULL
receptor	NULL
(	NULL
10-14	NULL
)	NULL
and	NULL
cytokine	NULL
receptors	NULL
(	NULL
7	NULL
,	NULL
14-16	NULL
)	NULL
causes	NULL
an	NULL
increase	NULL
in	NULL
the	NULL
phosphotyrosine	NULL
(	NULL
Tyr	NULL
(	NULL
P	NULL
)	NULL
)	NULL
'	NULL
content	NULL
of	NULL
Cbl	NULL
,	NULL
and	NULL
tyrosine-phosphorylated	NULL
Cbl	NULL
associates	NULL
with	NULL
SH2	NULL
domains	NULL
of	NULL
the	NULL
regulatory	NULL
subunit	NULL
(	NULL
p85	NULL
)	NULL
of	NULL
phosphatidylinositol	NULL
3-kinase	NULL
(	NULL
PI38-K	NULL
)	NULL
(	NULL
5-7	NULL
,	NULL
13	NULL
,	NULL
17	NULL
,	NULL
18	NULL
)	NULL
and	NULL
Crk	NULL
(	NULL
19-21	NULL
)	NULL
in	NULL
an	NULL
activation-dependent	NULL
manner	NULL
.	NULL

Third	NULL
,	NULL
we	NULL
found	NULL
recently	NULL
that	NULL
in	NULL
T	NULL
cells	NULL
,	NULL
Cbl	NULL
interacts	NULL
with	NULL
14-3-3	NULL
proteins	NULL
,	NULL
and	NULL
that	NULL
this	NULL
association	NULL
is	NULL
increased	NULL
upon	NULL
TCR	NULL
stimulation	NULL
(	NULL
22	NULL
)	NULL
.	NULL

14-3-3	NULL
proteins	NULL
are	NULL
thought	NULL
to	NULL
participate	NULL
in	NULL
signal	NULL
transduction	NULL
pathways	NULL
via	NULL
their	NULL
association	NULL
with	NULL
different	NULL
oncogene	NULL
and	NULL
protooncogene	NULL
products	NULL
(	NULL
23	NULL
,	NULL
24	NULL
)	NULL
.	NULL

Despite	NULL
all	NULL
of	NULL
these	NULL
findings	NULL
,	NULL
however	NULL
,	NULL
the	NULL
physiological	NULL
function	NULL
of	NULL
mammalian	NULL
Cbl	NULL
remains	NULL
unclear	NULL
.	NULL

Cbl	NULL
is	NULL
also	NULL
likely	NULL
to	NULL
participate	NULL
in	NULL
signaling	NULL
pathways	NULL
initiated	NULL
by	NULL
the	NULL
T	NULL
cell	NULL
antigen	NULL
receptor	NULL
(	NULL
TCR	NULL
)	NULL
-CD3	NULL
complex	NULL
and	NULL
other	NULL
immune	NULL
recognition	NULL
receptors	NULL
,	NULL
i.e	NULL
.	NULL

the	NULL
B	NULL
cell	NULL
antigen	NULL
receptor	NULL
(	NULL
18	NULL
,	NULL
25	NULL
)	NULL
,	NULL
and	NULL
the	NULL
IgG-Fc	NULL
receptor	NULL
(	NULL
14	NULL
,	NULL
26	NULL
)	NULL
.	NULL

TCR-CD3	NULL
ligation	NULL
by	NULL
processed	NULL
antigenic	NULL
peptides	NULL
or	NULL
anti-receptor	NULL
antibodies	NULL
leads	NULL
to	NULL
activation	NULL
of	NULL
protein	NULL
tyrosine	NULL
kinases	NULL
of	NULL
the	NULL
Src	NULL
and	NULL
Syk	NULL
families	NULL
(	NULL
27	NULL
,	NULL
28	NULL
)	NULL
which	NULL
,	NULL
in	NULL
turn	NULL
,	NULL
phosphorylate	NULL
multiple	NULL
cellular	NULL
proteins	NULL
.	NULL

These	NULL
early	NULL
events	NULL
trigger	NULL
signal	NULL
transduction	NULL
cascades	NULL
which	NULL
lead	NULL
to	NULL
T	NULL
cell	NULL
activation	NULL
,	NULL
lymphokine	NULL
production	NULL
,	NULL
and	NULL
proliferation	NULL
.	NULL

Cbl	NULL
was	NULL
recently	NULL
identified	NULL
as	NULL
a	NULL
prominent	NULL
protein	NULL
tyrosine	NULL
kinase	NULL
substrate	NULL
in	NULL
TCR-stimu-lated	NULL
T	NULL
cells	NULL
(	NULL
5	NULL
,	NULL
6	NULL
,	NULL
21	NULL
,	NULL
29	NULL
)	NULL
,	NULL
and	NULL
was	NULL
found	NULL
to	NULL
associate	NULL
with	NULL
two	NULL
protein	NULL
tyrosine	NULL
kinases	NULL
,	NULL
i.e	NULL
.	NULL

Fyn	NULL
(	NULL
5	NULL
,	NULL
29	NULL
,	NULL
30	NULL
)	NULL
and	NULL
ZAP-70	NULL
(	NULL
30	NULL
)	NULL
,	NULL
in	NULL
activated	NULL
T	NULL
cells	NULL
.	NULL

Furthermore	NULL
,	NULL
ZAP-70	NULL
causes	NULL
increased	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
Cbl	NULL
in	NULL
an	NULL
Lck-	NULL
and	NULL
Fyn-dependent	NULL
manner	NULL
(	NULL
30	NULL
)	NULL
,	NULL
indicating	NULL
that	NULL
Cbl	NULL
may	NULL
couple	NULL
ZAP-70	NULL
to	NULL
downstream	NULL
signaling	NULL
events	NULL
during	NULL
T	NULL
cell	NULL
activation	NULL
.	NULL

In	NULL
order	NULL
to	NULL
begin	NULL
to	NULL
address	NULL
the	NULL
role	NULL
of	NULL
Cbl	NULL
in	NULL
TCRCD3-mediated	NULL
signaling	NULL
,	NULL
we	NULL
evaluated	NULL
the	NULL
effects	NULL
of	NULL
wild-type	NULL
or	NULL
a	NULL
mutated	NULL
form	NULL
(	NULL
702/83	NULL
)	NULL
of	NULL
Cbl	NULL
on	NULL
the	NULL
transcriptional	NULL
activation	NULL
of	NULL
nuclear	NULL
factor	NULL
of	NULL
activated	NULL
T	NULL
cells	NULL
(	NULL
NFAT	NULL
)	NULL
,	NULL
using	NULL
transient	NULL
transfection	NULL
assays	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
.	NULL

NFAT	NULL
is	NULL
a	NULL
transcription	NULL
factor	NULL
complex	NULL
that	NULL
plays	NULL
a	NULL
critical	NULL
role	NULL
in	NULL
the	NULL
induction	NULL
of	NULL
interleukin	NULL
2	NULL
(	NULL
IL2	NULL
)	NULL
and	NULL
other	NULL
cytokine	NULL
genes	NULL
,	NULL
and	NULL
the	NULL
two	NULL
signal	NULL
requirement	NULL
for	NULL
its	NULL
activation	NULL
mimicks	NULL
the	NULL
requirement	NULL
for	NULL
optimal	NULL
proliferation	NULL
and	NULL
IL2	NULL
production	NULL
in	NULL
TCR-CD3-activated	NULL
T	NULL
cells	NULL
(	NULL
31	NULL
,	NULL
32	NULL
)	NULL
.	NULL

NFAT-reporter	NULL
gene	NULL
activation	NULL
in	NULL
transiently	NULL
*	NULL
The	NULL
abbreviations	NULL
used	NULL
are	NULL
:	NULL
Tyr	NULL
(	NULL
P	NULL
)	NULL
,	NULL
phosphotyrosine	NULL
;	NULL
TCR	NULL
,	NULL
T	NULL
cell	NULL
antigen	NULL
receptor	NULL
;	NULL
PI8-K	NULL
,	NULL
phophatidylinositol	NULL
3-kinase	NULL
;	NULL
NFAT	NULL
,	NULL
nuclear	NULL
factor	NULL
of	NULL
activated	NULL
T	NULL
cells	NULL
;	NULL
PMA	NULL
,	NULL
phorbol	NULL
myristate	NULL
acetate	NULL
;	NULL
mAb	NULL
,	NULL
monoclonal	NULL
antibody	NULL
;	NULL
HA	NULL
,	NULL
hemagglutinin	NULL
;	NULL
IL	NULL
,	NULL
interleukin	NULL
.	NULL

168	NULL
This	NULL
paper	NULL
is	NULL
available	NULL
on	NULL
line	NULL
at	NULL
http	NULL
:	NULL
//www-jbc.stanford.edu/jbc/	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
4g	NULL
/810-0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wo	NULL
;	NULL
popeoumog	NULL
Ras-dependent	NULL
,	NULL
Ca	NULL
``	NULL
*	NULL
-stimulated	NULL
Activation	NULL
of	NULL
NFAT	NULL
169	NULL
transfected	NULL
T	NULL
cells	NULL
has	NULL
,	NULL
therefore	NULL
,	NULL
been	NULL
extensively	NULL
used	NULL
as	NULL
a	NULL
physiologically	NULL
relevant	NULL
assay	NULL
for	NULL
analyzing	NULL
molecular	NULL
events	NULL
associated	NULL
with	NULL
T	NULL
cell	NULL
activation	NULL
.	NULL

We	NULL
report	NULL
that	NULL
transient	NULL
overexpression	NULL
of	NULL
70	NULL
%	NULL
/3	NULL
(	NULL
but	NULL
not	NULL
wild-type	NULL
Cbl	NULL
)	NULL
induces	NULL
an	NULL
increase	NULL
in	NULL
the	NULL
basal	NULL
activity	NULL
of	NULL
NFAT	NULL
,	NULL
which	NULL
is	NULL
further	NULL
enhanced	NULL
synergistically	NULL
by	NULL
calcium	NULL
ionophore	NULL
.	NULL

This	NULL
NFAT	NULL
induction	NULL
is	NULL
dependent	NULL
on	NULL
both	NULL
calcineurin	NULL
and	NULL
functional	NULL
Ras	NULL
.	NULL

These	NULL
results	NULL
provide	NULL
evidence	NULL
that	NULL
Cbl	NULL
is	NULL
involved	NULL
in	NULL
Ras-dependent	NULL
T	NULL
cell	NULL
signaling	NULL
pathways	NULL
that	NULL
lead	NULL
to	NULL
the	NULL
transcriptional	NULL
activation	NULL
of	NULL
cytokine	NULL
genes	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Antibodies-The	NULL
anti-CD3e	NULL
monoclonal	NULL
antibody	NULL
(	NULL
mAb	NULL
)	NULL
,	NULL
OKT3	NULL
,	NULL
was	NULL
purified	NULL
from	NULL
culture	NULL
supernatants	NULL
of	NULL
the	NULL
corresponding	NULL
hybridoma	NULL
by	NULL
protein	NULL
A-Sepharose	NULL
affinity	NULL
chromatography	NULL
.	NULL

Polyclonal	NULL
rabbit	NULL
anti-Chl	NULL
antibody	NULL
was	NULL
from	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
(	NULL
Santa	NULL
Cruz	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

The	NULL
4G10	NULL
anti-Tyr	NULL
(	NULL
P	NULL
)	NULL
mAb	NULL
and	NULL
a	NULL
rabbit	NULL
anti-p85	NULL
antibody	NULL
were	NULL
purchased	NULL
from	NULL
Upstate	NULL
Biotechnology	NULL
(	NULL
Lake	NULL
Placid	NULL
,	NULL
NY	NULL
)	NULL
.	NULL

Anti-hemagglutinin	NULL
(	NULL
HA	NULL
;	NULL
12CA5	NULL
)	NULL
or	NULL
anti-Grb2	NULL
mAbs	NULL
were	NULL
from	NULL
Boehringer	NULL
Mannheim	NULL
and	NULL
Transduction	NULL
Laboratories	NULL
(	NULL
Lexington	NULL
,	NULL
KY	NULL
)	NULL
,	NULL
respectively	NULL
.	NULL

Horseradish	NULL
peroxidase-conjugated	NULL
donkey	NULL
anti-rabbit	NULL
or	NULL
sheep	NULL
anti-mouse	NULL
IgG	NULL
F	NULL
(	NULL
ab	NULL
'	NULL
)	NULL
,	NULL
fragments	NULL
were	NULL
from	NULL
Amersham	NULL
Corp.	NULL
Plasmids-The	NULL
cDNAs	NULL
encoding	NULL
human	NULL
c-Cbl	NULL
,	NULL
v-Cbl	NULL
,	NULL
or	NULL
the	NULL
homologue	NULL
of	NULL
murine	NULL
702/83	NULL
(	NULL
representing	NULL
an	NULL
internal	NULL
17-amino	NULL
acid	NULL
deletion	NULL
of	NULL
Cbl	NULL
)	NULL
were	NULL
subcloned	NULL
from	NULL
the	NULL
pGEM-2z	NULL
vector	NULL
into	NULL
a	NULL
mammalian	NULL
expression	NULL
vector	NULL
,	NULL
pEFneo	NULL
(	NULL
83	NULL
)	NULL
at	NULL
the	NULL
EcoRI	NULL
and	NULL
Xbal	NULL
sites	NULL
to	NULL
generate	NULL
pEFneo-Cbl	NULL
,	NULL
pEFneo-v-Cbl	NULL
,	NULL
and	NULL
pEFneo-702/8	NULL
,	NULL
respectively	NULL
.	NULL

A	NULL
sequence	NULL
encoding	NULL
an	NULL
HA	NULL
tag	NULL
epitope	NULL
has	NULL
been	NULL
added	NULL
to	NULL
the	NULL
5	NULL
end	NULL
of	NULL
the	NULL
702/83	NULL
cDNA	NULL
by	NULL
a	NULL
standard	NULL
polymerase	NULL
chain	NULL
reaction	NULL
.	NULL

A	NULL
methionine	NULL
to	NULL
cysteine	NULL
mutation	NULL
at	NULL
a	NULL
potential	NULL
PIS-K-binding	NULL
motif	NULL
in	NULL
Cbl	NULL
(	NULL
Y**EAM	NULL
)	NULL
was	NULL
introduced	NULL
by	NULL
polymerase	NULL
chain	NULL
reaction	NULL
amplification	NULL
of	NULL
a	NULL
cDNA	NULL
fragment	NULL
encoding	NULL
the	NULL
Y*EAC	NULL
mutation	NULL
and	NULL
ligation	NULL
of	NULL
the	NULL
product	NULL
into	NULL
the	NULL
TA	NULL
cloning	NULL
vector	NULL
(	NULL
InVitrogen	NULL
)	NULL
.	NULL

The	NULL
sequence	NULL
was	NULL
verified	NULL
by	NULL
nucleotide	NULL
sequencing	NULL
,	NULL
and	NULL
the	NULL
cDNA	NULL
fragment	NULL
digested	NULL
with	NULL
SnaBI	NULL
and	NULL
Xbal	NULL
was	NULL
ligated	NULL
into	NULL
pEFneo-702/3	NULL
which	NULL
has	NULL
been	NULL
digested	NULL
with	NULL
the	NULL
corresponding	NULL
enzymes	NULL
to	NULL
create	NULL
the	NULL
expression	NULL
vector	NULL
.	NULL

To	NULL
construct	NULL
expression	NULL
plasmids	NULL
encoding	NULL
702/83	NULL
proteins	NULL
with	NULL
successive	NULL
deletions	NULL
of	NULL
their	NULL
114	NULL
,	NULL
176	NULL
,	NULL
346	NULL
,	NULL
866	NULL
,	NULL
or	NULL
456	NULL
C-terminal	NULL
residues	NULL
,	NULL
internal	NULL
restriction	NULL
sites	NULL
or	NULL
a	NULL
point	NULL
mutation	NULL
were	NULL
used	NULL
to	NULL
generate	NULL
plasmids	NULL
Al	NULL
(	NULL
deletion	NULL
of	NULL
an	NULL
EcoRV-Xbal	NULL
fragment	NULL
)	NULL
,	NULL
A2	NULL
(	NULL
deletion	NULL
of	NULL
a	NULL
SnaBI-Xbal	NULL
fragment	NULL
)	NULL
,	NULL
A8	NULL
(	NULL
point	NULL
mutation	NULL
of	NULL
the	NULL
proline-560	NULL
codon	NULL
to	NULL
a	NULL
stop	NULL
codon	NULL
by	NULL
polymerase	NULL
chain	NULL
reaction	NULL
)	NULL
,	NULL
A4	NULL
(	NULL
deletion	NULL
of	NULL
a	NULL
Bgill-Xbal	NULL
fragment	NULL
)	NULL
,	NULL
and	NULL
A5	NULL
(	NULL
deletion	NULL
of	NULL
a	NULL
Sacl-Xbal	NULL
fragment	NULL
)	NULL
,	NULL
respectively	NULL
(	NULL
see	NULL
Fig	NULL
.	NULL

5A	NULL
)	NULL
.	NULL

These	NULL
deletions	NULL
removed	NULL
distinct	NULL
proline-rich	NULL
sequences	NULL
of	NULL
the	NULL
protein	NULL
.	NULL

The	NULL
deletion	NULL
mutants	NULL
were	NULL
ligated	NULL
into	NULL
the	NULL
pEFneo	NULL
vector	NULL
.	NULL

The	NULL
luciferase	NULL
reporter	NULL
plasmids	NULL
,	NULL
NFAT-Lue	NULL
and	NULL
IL2-Luc	NULL
,	NULL
were	NULL
generous	NULL
gifts	NULL
from	NULL
Dr.	NULL
G.	NULL
Grabtree	NULL
;	NULL
AP-1-Lue	NULL
and	NULL
were	NULL
kindly	NULL
provided	NULL
by	NULL
Dr.	NULL
M.	NULL
Karin	NULL
.	NULL

The	NULL
dominant	NULL
negative	NULL
H-RasN17	NULL
plasmid	NULL
in	NULL
the	NULL
pcDNA	NULL
vector	NULL
was	NULL
obtained	NULL
from	NULL
Dr.	NULL
H.	NULL
Wang	NULL
.	NULL

Cell	NULL
Culture	NULL
and	NULL
Transfection-Simian	NULL
virus	NULL
40	NULL
T	NULL
antigen	NULL
(	NULL
TAg	NULL
)	NULL
-transfected	NULL
human	NULL
leukemic	NULL
Jurkat	NULL
T	NULL
cells	NULL
(	NULL
Jurkat-TAg	NULL
)	NULL
were	NULL
grown	NULL
in	NULL
RPMI	NULL
1640	NULL
medium	NULL
(	NULL
Life	NULL
Technologies	NULL
,	NULL
Inc.	NULL
)	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
fetal	NULL
bovine	NULL
serum	NULL
(	NULL
Harlan	NULL
,	NULL
Indianapolis	NULL
,	NULL
IN	NULL
)	NULL
,	NULL
L-glutamine	NULL
,	NULL
and	NULL
antibi-otics	NULL
.	NULL

Cells	NULL
in	NULL
a	NULL
logarithmic	NULL
growth	NULL
phase	NULL
were	NULL
transfected	NULL
with	NULL
the	NULL
indicated	NULL
amount	NULL
(	NULL
usually	NULL
10	NULL
pg	NULL
)	NULL
of	NULL
Cbl	NULL
plasmid	NULL
DNA	NULL
and	NULL
5	NULL
pug	NULL
of	NULL
the	NULL
reporter	NULL
plasmid	NULL
by	NULL
electroporation	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
22	NULL
,	NULL
34	NULL
)	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
transferred	NULL
to	NULL
24-well	NULL
plate	NULL
24	NULL
h	NULL
later	NULL
and	NULL
cultured	NULL
in	NULL
1	NULL
ml	NULL
of	NULL
RPMI	NULL
1640	NULL
medium	NULL
containing	NULL
0.2	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
for	NULL
4-6	NULL
h.	NULL
The	NULL
transfected	NULL
cells	NULL
were	NULL
then	NULL
left	NULL
unstimulated	NULL
or	NULL
stimulated	NULL
with	NULL
an	NULL
anti-CD38e	NULL
mAb	NULL
(	NULL
OKT3	NULL
;	NULL
10	NULL
ug/m1	NULL
)	NULL
,	NULL
ionomycin	NULL
(	NULL
100	NULL
ng/m	NULL
!	NULL

1	NULL
)	NULL
,	NULL
and/or	NULL
phorbol	NULL
myristate	NULL
acetate	NULL
(	NULL
PMA	NULL
;	NULL
10	NULL
ng/ml	NULL
)	NULL
for	NULL
another	NULL
8-10	NULL
h.	NULL
In	NULL
some	NULL
experiments	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
treated	NULL
in	NULL
triplicate	NULL
with	NULL
cyclosporin	NULL
A	NULL
(	NULL
50	NULL
ng/ml	NULL
)	NULL
for	NULL
10	NULL
min	NULL
prior	NULL
to	NULL
stimulation	NULL
.	NULL

In	NULL
order	NULL
to	NULL
assess	NULL
the	NULL
effect	NULL
of	NULL
dominant	NULL
negative	NULL
Ras	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
a	NULL
mixture	NULL
of	NULL
5	NULL
ug	NULL
of	NULL
pEFneo-702/83	NULL
,	NULL
10	NULL
ug	NULL
of	NULL
RasN17	NULL
,	NULL
and	NULL
5	NULL
ug	NULL
of	NULL
reporter	NULL
plasmid	NULL
DNAs	NULL
.	NULL

Similar	NULL
amounts	NULL
of	NULL
the	NULL
corresponding	NULL
empty	NULL
vectors	NULL
were	NULL
used	NULL
as	NULL
controls	NULL
in	NULL
all	NULL
transfection	NULL
experiments	NULL
.	NULL

Luciferase	NULL
Assay-Transfected	NULL
Jurkat-TAg	NULL
cells	NULL
were	NULL
harvested	NULL
and	NULL
lysed	NULL
in	NULL
100	NULL
pl	NULL
of	NULL
lysis	NULL
buffer	NULL
(	NULL
100	NULL
mM	NULL
KPO	NULL
,	NULL
,	NULL
pH	NULL
7.8	NULL
,	NULL
10	NULL
mM	NULL
dithiothre-itol	NULL
,	NULL
0.2	NULL
%	NULL
Triton	NULL
X-100	NULL
)	NULL
for	NULL
10	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
.	NULL

The	NULL
lysates	NULL
were	NULL
then	NULL
centrifuged	NULL
(	NULL
15,000	NULL
x	NULL
g	NULL
,	NULL
5	NULL
min	NULL
)	NULL
,	NULL
and	NULL
their	NULL
protein	NULL
content	NULL
was	NULL
determined	NULL
in	NULL
an	NULL
ELISA	NULL
plate	NULL
reader	NULL
(	NULL
Bio-Rad	NULL
)	NULL
using	NULL
a	NULL
Bio-Rad	NULL
microassay	NULL
.	NULL

Aliquots	NULL
of	NULL
the	NULL
lysates	NULL
(	NULL
80-50	NULL
ul	NULL
)	NULL
normalized	NULL
to	NULL
the	NULL
same	NULL
protein	NULL
concentration	NULL
were	NULL
mixed	NULL
with	NULL
100	NULL
ul	NULL
of	NULL
assay	NULL
buffer	NULL
(	NULL
17.5	NULL
mM	NULL
glycyl-glycine	NULL
,	NULL
pH	NULL
7.8	NULL
,	NULL
10	NULL
mM	NULL
MgCl	NULL
,	NULL
,	NULL
5	NULL
mM	NULL
ATP	NULL
,	NULL
0.185	NULL
mM	NULL
coenzyme	NULL
A	NULL
,	NULL
0.285	NULL
mM	NULL
luciferin	NULL
)	NULL
.	NULL

Luciferase	NULL
activity	NULL
was	NULL
determined	NULL
in	NULL
triplicate	NULL
and	NULL
expressed	NULL
as	NULL
arbitrary	NULL
units	NULL
(	NULL
AU	NULL
)	NULL
.	NULL

The	NULL
standard	NULL
deviation	NULL
among	NULL
triplicates	NULL
was	NULL
<	NULL
10	NULL
%	NULL
,	NULL
and	NULL
each	NULL
experiment	NULL
was	NULL
repeated	NULL
at	NULL
least	NULL
three	NULL
times	NULL
.	NULL

Immunoprecipitation	NULL
,	NULL
Immunoblotting	NULL
,	NULL
and	NULL
PI3-K	NULL
Assoy-Immuno-precipitation	NULL
,	NULL
immunoblotting	NULL
,	NULL
and	NULL
PIS-K	NULL
enzymatic	NULL
assays	NULL
were	NULL
performed	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
22	NULL
,	NULL
34	NULL
)	NULL
.	NULL

RESULTS	NULL
Overexpression	NULL
of	NULL
70Z/3	NULL
Induces	NULL
NFAT	NULL
Activity	NULL
Which	NULL
Is	NULL
Synergistic	NULL
with	NULL
Ionomycin	NULL
Stimulation-To	NULL
explore	NULL
whether	NULL
Cbl	NULL
or	NULL
70Z	NULL
%	NULL
/3	NULL
can	NULL
transduce	NULL
signals	NULL
leading	NULL
to	NULL
IL2	NULL
gene	NULL
transcription	NULL
,	NULL
we	NULL
evaluated	NULL
the	NULL
effects	NULL
of	NULL
cotransfected	NULL
Cbl	NULL
or	NULL
702/83	NULL
cDNA	NULL
on	NULL
the	NULL
transcriptional	NULL
activity	NULL
of	NULL
an	NULL
IL2	NULL
promoter-re-porter	NULL
plasmid	NULL
(	NULL
IL2-Luc	NULL
)	NULL
,	NULL
or	NULL
reporters	NULL
corresponding	NULL
to	NULL
defined	NULL
response	NULL
elements	NULL
in	NULL
the	NULL
IL2	NULL
promoter	NULL
,	NULL
i.e	NULL
.	NULL

,	NULL
NFAT-Luc	NULL
,	NULL
NFxB-Luc	NULL
or	NULL
AP-1-Luc	NULL
,	NULL
in	NULL
Jurkat-TAg	NULL
cells	NULL
.	NULL

Cell	NULL
lysates	NULL
were	NULL
assayed	NULL
for	NULL
luciferase	NULL
activity	NULL
following	NULL
culture	NULL
in	NULL
low	NULL
serum-containing	NULL
medium	NULL
and	NULL
stimulation	NULL
with	NULL
ionomycin	NULL
and/or	NULL
PMA	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

1A	NULL
,	NULL
when	NULL
the	NULL
full-length	NULL
Cbl	NULL
was	NULL
transfected	NULL
into	NULL
unstimulated	NULL
Jurkat	NULL
T	NULL
cells	NULL
,	NULL
no	NULL
increase	NULL
(	NULL
or	NULL
a	NULL
slight	NULL
decrease	NULL
)	NULL
in	NULL
NFAT	NULL
activity	NULL
was	NULL
observed	NULL
by	NULL
comparison	NULL
with	NULL
the	NULL
empty	NULL
control	NULL
vector	NULL
.	NULL

Similarly	NULL
,	NULL
Cbl	NULL
did	NULL
not	NULL
activate	NULL
NFAT	NULL
in	NULL
ionomy-cin-	NULL
or	NULL
PMA-stimulated	NULL
cells	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
transient	NULL
overexpression	NULL
of	NULL
702/383	NULL
induced	NULL
a	NULL
~3-4-fold	NULL
increase	NULL
of	NULL
NFAT	NULL
activity	NULL
in	NULL
unstimulated	NULL
cells	NULL
,	NULL
and	NULL
stimulation	NULL
of	NULL
the	NULL
70	NULL
%	NULL
/3-transfected	NULL
cells	NULL
with	NULL
ionomycin	NULL
which	NULL
was	NULL
minimally	NULL
active	NULL
by	NULL
itself	NULL
(	NULL
~2-fold	NULL
activation	NULL
)	NULL
,	NULL
but	NULL
not	NULL
with	NULL
PMA	NULL
,	NULL
resulted	NULL
in	NULL
a	NULL
synergistic	NULL
effect	NULL
(	NULL
~70-fold	NULL
NFAT	NULL
activation	NULL
)	NULL
.	NULL

Cbl	NULL
or	NULL
702/83	NULL
did	NULL
not	NULL
cause	NULL
detectable	NULL
activation	NULL
of	NULL
AP-1	NULL
,	NULL
and	NULL
70	NULL
%	NULL
/3	NULL
overexpression	NULL
led	NULL
to	NULL
only	NULL
a	NULL
slight	NULL
induction	NULL
of	NULL
the	NULL
IL2	NULL
promoter	NULL
and	NULL
NFkB	NULL
under	NULL
unstimulated	NULL
or	NULL
stimulated	NULL
conditions	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

To	NULL
rule	NULL
out	NULL
the	NULL
possibility	NULL
that	NULL
the	NULL
observed	NULL
difference	NULL
between	NULL
Cbl	NULL
and	NULL
702/3	NULL
was	NULL
due	NULL
to	NULL
different	NULL
expression	NULL
levels	NULL
of	NULL
the	NULL
two	NULL
proteins	NULL
,	NULL
we	NULL
assessed	NULL
protein	NULL
expression	NULL
by	NULL
immunoblotting	NULL
cell	NULL
lysates	NULL
with	NULL
an	NULL
anti-Cbl	NULL
antibody	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

1B	NULL
,	NULL
transient	NULL
transfection	NULL
of	NULL
Cbl	NULL
or	NULL
702/83	NULL
increased	NULL
the	NULL
intracellular	NULL
level	NULL
of	NULL
a	NULL
120-kDa	NULL
protein	NULL
which	NULL
was	NULL
recognized	NULL
by	NULL
anti-Cbl	NULL
antibody	NULL
to	NULL
a	NULL
similar	NULL
degree	NULL
.	NULL

The	NULL
70	NULL
%	NULL
/3	NULL
protein	NULL
could	NULL
also	NULL
be	NULL
detected	NULL
with	NULL
an	NULL
anti-HA	NULL
antibody	NULL
,	NULL
since	NULL
an	NULL
HA	NULL
tag	NULL
was	NULL
added	NULL
to	NULL
its	NULL
N	NULL
terminus	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
.	NULL

Collectively	NULL
,	NULL
these	NULL
results	NULL
indicate	NULL
that	NULL
702/83	NULL
is	NULL
constitutively	NULL
active	NULL
in	NULL
T	NULL
cells	NULL
in	NULL
terms	NULL
of	NULL
its	NULL
ability	NULL
to	NULL
induce	NULL
NFAT-dependent	NULL
transcription	NULL
,	NULL
and	NULL
synergizes	NULL
with	NULL
a	NULL
Ca	NULL
``	NULL
``	NULL
-dependent	NULL
signal	NULL
in	NULL
this	NULL
regard	NULL
.	NULL

The	NULL
former	NULL
observation	NULL
is	NULL
consistent	NULL
with	NULL
the	NULL
finding	NULL
that	NULL
70	NULL
%	NULL
/3	NULL
can	NULL
transform	NULL
fibroblasts	NULL
(	NULL
4	NULL
)	NULL
.	NULL

Calcineurin	NULL
,	NULL
a	NULL
calcium-calmodulin	NULL
dependent	NULL
phosphatase	NULL
which	NULL
plays	NULL
a	NULL
critical	NULL
role	NULL
in	NULL
NFAT	NULL
induction	NULL
,	NULL
is	NULL
a	NULL
major	NULL
target	NULL
for	NULL
the	NULL
immunosuppressive	NULL
effect	NULL
of	NULL
cyclosporin	NULL
A	NULL
and	NULL
FK506	NULL
(	NULL
35	NULL
,	NULL
36	NULL
)	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
70¥/3-induced	NULL
NFAT	NULL
activation	NULL
is	NULL
dependent	NULL
on	NULL
calcineurin	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
pretreated	NULL
with	NULL
cyclosporin	NULL
A	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

1C	NULL
,	NULL
cyclosporin	NULL
A	NULL
blocked	NULL
the	NULL
ionomycin-stimulated	NULL
increase	NULL
in	NULL
NFAT	NULL
activity	NULL
in	NULL
cells	NULL
transfected	NULL
with	NULL
the	NULL
empty	NULL
vector	NULL
,	NULL
as	NULL
well	NULL
as	NULL
the	NULL
synergistic	NULL
effect	NULL
of	NULL
702/83	NULL
plus	NULL
ionomycin	NULL
.	NULL

This	NULL
suggests	NULL
that	NULL
functional	NULL
calcineurin	NULL
is	NULL
required	NULL
for	NULL
the	NULL
70	NULL
%	NULL
/3-mediated	NULL
signal	NULL
which	NULL
leads	NULL
to	NULL
the	NULL
transactivation	NULL
of	NULL
NFAT	NULL
.	NULL

v-Cbl	NULL
Fails	NULL
to	NULL
Activate	NULL
NFAT-Cbl	NULL
was	NULL
originally	NULL
isolated	NULL
as	NULL
a	NULL
product	NULL
of	NULL
a	NULL
transforming	NULL
viral	NULL
oncogene	NULL
(	NULL
v-cbl	NULL
)	NULL
.	NULL

Since	NULL
both	NULL
v-Cbl	NULL
(	NULL
1	NULL
)	NULL
and	NULL
70	NULL
%	NULL
/3	NULL
(	NULL
4	NULL
)	NULL
possess	NULL
transforming	NULL
activity	NULL
,	NULL
we	NULL
wished	NULL
to	NULL
determine	NULL
whether	NULL
v-Cbl	NULL
shares	NULL
with	NULL
702/38	NULL
the	NULL
ability	NULL
to	NULL
activate	NULL
NFAT	NULL
.	NULL

When	NULL
cells	NULL
expressing	NULL
the	NULL
NFAT-Luc	NULL
reporter	NULL
plasmid	NULL
were	NULL
cotransfected	NULL
with	NULL
702/3	NULL
,	NULL
an	NULL
increase	NULL
of	NULL
3-	NULL
and	NULL
60-fold	NULL
in	NULL
NFAT	NULL
activity	NULL
was	NULL
detected	NULL
in	NULL
the	NULL
absence	NULL
or	NULL
presence	NULL
of	NULL
ionomycin	NULL
stimulation	NULL
,	NULL
respectively	NULL
,	NULL
consistent	NULL
with	NULL
the	NULL
results	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
cotransfection	NULL
with	NULL
the	NULL
v-Cbl	NULL
expression	NULL
vector	NULL
failed	NULL
to	NULL
stimulate	NULL
the	NULL
basal	NULL
or	NULL
ionomycin-induced	NULL
NFAT	NULL
activity	NULL
(	NULL
Fig	NULL
.	NULL

24	NULL
)	NULL
.	NULL

This	NULL
difference	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
4g	NULL
/810-0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wo	NULL
;	NULL
popeoumog	NULL
170	NULL
Ras-dependent	NULL
,	NULL
Ca	NULL
``	NULL
*	NULL
-stimulated	NULL
Activation	NULL
of	NULL
NFAT	NULL
A	NULL
80	NULL
[	NULL
]	NULL
pBFneo	NULL
.	NULL

G	NULL
c	NULL
»	NULL
g	NULL
60	NULL
-	NULL
10273	NULL
3	NULL
T	NULL
o	NULL
3	NULL
H	NULL
4g	NULL
-I	NULL
o	NULL
3	NULL
3	NULL
C	NULL
C4	NULL
20	NULL
,	NULL
!	NULL

-S3	NULL
control	NULL
ionomycin	NULL
PMA	NULL
Stimulation	NULL
0	NULL
B	NULL
é	NULL
S	NULL
2	NULL
m	NULL
Log	NULL
HL	NULL
og	NULL
d	NULL
5	NULL
5	NULL
CO	NULL
2	NULL
2	NULL
C	NULL
2	NULL
MW	NULL
MW	NULL
__	NULL
cap	NULL
cms	NULL
cam	NULL
98-	NULL
-	NULL
98	NULL
<	NULL
a=	NULL
a	NULL
64-	NULL
jmigd	NULL
64	NULL
!	NULL

am	NULL
ste	NULL
50-	NULL
5C	NULL
Blot	NULL
:	NULL
anti-Cbl	NULL
Blot	NULL
:	NULL
anti-HA	NULL
80	NULL
D	NULL
pEFneo	NULL
>	NULL
§	NULL
co	NULL
Sme	NULL
10273	NULL
bst	NULL
<	NULL
2	NULL
»	NULL
40-7	NULL
A	NULL
3	NULL
o	NULL
)	NULL
+s	NULL
207	NULL
.	NULL

J-	NULL
$	NULL
cus	NULL
control	NULL
jono	NULL
CsA/iono	NULL
Stimulation	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

NFAT	NULL
activation	NULL
by	NULL
702	NULL
%	NULL
/3	NULL
.	NULL

A	NULL
,	NULL
Jurkat-TAg	NULL
T	NULL
cells	NULL
were	NULL
cotransfected	NULL
with	NULL
an	NULL
NFAT-Lue	NULL
reporter	NULL
plasmid	NULL
plus	NULL
either	NULL
empty	NULL
pEFneo	NULL
vector	NULL
,	NULL
or	NULL
pEFneo	NULL
vectors	NULL
expressing	NULL
Chl	NULL
or	NULL
702/83	NULL
.	NULL

Following	NULL
culture	NULL
and	NULL
stimulation	NULL
as	NULL
indicated	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
lysed	NULL
,	NULL
and	NULL
extracts	NULL
were	NULL
assayed	NULL
for	NULL
luciferase	NULL
activity	NULL
.	NULL

Bars	NULL
represent	NULL
the	NULL
mean	NULL
of	NULL
triplicate	NULL
samples	NULL
.	NULL

B	NULL
,	NULL
aliquots	NULL
of	NULL
the	NULL
same	NULL
lysates	NULL
were	NULL
subjected	NULL
to	NULL
SDS-12.5	NULL
%	NULL
polyacrylamide	NULL
gel	NULL
electrophoresis	NULL
,	NULL
and	NULL
Cbl	NULL
expression	NULL
was	NULL
assessed	NULL
by	NULL
immunoblotting	NULL
with	NULL
anti-Cbl	NULL
(	NULL
eff	NULL
)	NULL
or	NULL
anti-HA	NULL
(	NULL
right	NULL
)	NULL
antibodies	NULL
.	NULL

Molecular	NULL
mass	NULL
(	NULL
MW	NULL
)	NULL
standards	NULL
are	NULL
shown	NULL
(	NULL
X	NULL
1000	NULL
)	NULL
.	NULL

C	NULL
,	NULL
aliquots	NULL
of	NULL
the	NULL
transfected	NULL
cells	NULL
were	NULL
pretreated	NULL
with	NULL
cyclosporin	NULL
A	NULL
(	NULL
CsA	NULL
)	NULL
prior	NULL
to	NULL
ionomycin	NULL
(	NULL
ono	NULL
)	NULL
stimulation	NULL
,	NULL
and	NULL
luciferase	NULL
activity	NULL
was	NULL
measured	NULL
as	NULL
in	NULL
A	NULL
.	NULL

The	NULL
data	NULL
shown	NULL
in	NULL
A	NULL
and	NULL
C	NULL
are	NULL
representative	NULL
of	NULL
three	NULL
experiments	NULL
.	NULL

was	NULL
not	NULL
due	NULL
to	NULL
different	NULL
expression	NULL
levels	NULL
of	NULL
70/3	NULL
and	NULL
v-Cbl	NULL
,	NULL
since	NULL
immunoblotting	NULL
with	NULL
an	NULL
anti-HA	NULL
antibody	NULL
revealed	NULL
similar	NULL
expression	NULL
levels	NULL
of	NULL
the	NULL
two	NULL
transfected	NULL
proteins	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
despite	NULL
the	NULL
fact	NULL
that	NULL
both	NULL
v-Cbl	NULL
and	NULL
702/83	NULL
display	NULL
transforming	NULL
activity	NULL
,	NULL
only	NULL
is	NULL
capable	NULL
of	NULL
activating	NULL
NFAT	NULL
,	NULL
suggesting	NULL
that	NULL
transformation	NULL
by	NULL
the	NULL
two	NULL
proteins	NULL
involves	NULL
different	NULL
mechanisms	NULL
.	NULL

70Z/3-mediated	NULL
NFAT	NULL
Activation	NULL
Is	NULL
Independent	NULL
of	NULL
PI3-K	NULL
Association	NULL
with	NULL
70Z/3-TCR-CD3	NULL
cross-linking	NULL
causes	NULL
rapid	NULL
tyrosine	NULL
phophorylation	NULL
of	NULL
Cbl	NULL
which	NULL
,	NULL
in	NULL
turn	NULL
,	NULL
leads	NULL
to	NULL
an	NULL
association	NULL
of	NULL
Cbl	NULL
with	NULL
PI3-K	NULL
in	NULL
an	NULL
activation-dependent	NULL
manner	NULL
(	NULL
5	NULL
,	NULL
6	NULL
,	NULL
17	NULL
,	NULL
29	NULL
)	NULL
.	NULL

PI3-K	NULL
has	NULL
been	NULL
implicated	NULL
in	NULL
TCRCD3-	NULL
and	NULL
A	NULL
B	NULL
é	NULL
“	NULL
[	NULL
-	NULL
]	NULL
pEFneo	NULL
g	NULL
§	NULL
)	NULL
3	NULL
7023	NULL
6	NULL
S	NULL
Q	NULL
é	NULL
10	NULL
]	NULL
BO	NULL
web	NULL
!	NULL

So	NULL
g	NULL
MW	NULL
w	NULL
}	NULL
og-|	NULL
&	NULL
=	NULL
$	NULL
64-	NULL
<	NULL
*	NULL
;	NULL
50-	NULL
ma	NULL
20	NULL
36-1	NULL
o	NULL
--	NULL
-control	NULL
ionomycin	NULL
Stimulation	NULL
Fic	NULL
.	NULL

2.	NULL
v-Cbl	NULL
does	NULL
not	NULL
activate	NULL
NFAT	NULL
.	NULL

A	NULL
,	NULL
Jurkat-TAg	NULL
cells	NULL
were	NULL
cotransfected	NULL
with	NULL
the	NULL
NFAT-Luc	NULL
reporter	NULL
plasmid	NULL
plus	NULL
pEFneo	NULL
,	NULL
pEF-neo-702/3	NULL
,	NULL
or	NULL
pEFneo-v-cbl	NULL
,	NULL
left	NULL
unstimulated	NULL
or	NULL
stimulated	NULL
with	NULL
ionomycin	NULL
as	NULL
indicated	NULL
,	NULL
and	NULL
lysates	NULL
were	NULL
assayed	NULL
for	NULL
luciferase	NULL
activity	NULL
.	NULL

Bars	NULL
represent	NULL
the	NULL
mean	NULL
of	NULL
triplicate	NULL
samples	NULL
.	NULL

B	NULL
,	NULL
samples	NULL
of	NULL
the	NULL
same	NULL
lysates	NULL
were	NULL
separated	NULL
by	NULL
SDS-12.5	NULL
%	NULL
polyacrylamide	NULL
gel	NULL
electrophoresis	NULL
,	NULL
transferred	NULL
to	NULL
nitrocellulose	NULL
,	NULL
and	NULL
immunoblotted	NULL
with	NULL
a	NULL
mouse	NULL
anti-HA	NULL
antibody	NULL
.	NULL

Molecular	NULL
mass	NULL
(	NULL
MW	NULL
)	NULL
standards	NULL
are	NULL
shown	NULL
(	NULL
X	NULL
1000	NULL
)	NULL
.	NULL

or	NULL
CD28-mediated	NULL
signaling	NULL
events	NULL
leading	NULL
to	NULL
IL2	NULL
transcription	NULL
(	NULL
37	NULL
,	NULL
38	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
we	NULL
wished	NULL
to	NULL
address	NULL
the	NULL
possibility	NULL
that	NULL
an	NULL
activation-induced	NULL
CbI/PI3-K	NULL
association	NULL
plays	NULL
a	NULL
role	NULL
in	NULL
the	NULL
observed	NULL
NFAT	NULL
activation	NULL
mediated	NULL
by	NULL
702/38	NULL
.	NULL

Cbl	NULL
contains	NULL
two	NULL
potential	NULL
PI3-K-binding	NULL
motifs	NULL
(	NULL
39	NULL
)	NULL
,	NULL
ie	NULL
.	NULL

,	NULL
Y°	NULL
CEM	NULL
and	NULL
Y¥	NULL
``	NULL
*EAM	NULL
which	NULL
may	NULL
mediate	NULL
binding	NULL
to	NULL
the	NULL
SH2	NULL
domain	NULL
of	NULL
p85	NULL
(	NULL
17	NULL
)	NULL
.	NULL

The	NULL
first	NULL
of	NULL
these	NULL
motifs	NULL
is	NULL
deleted	NULL
in	NULL
70	NULL
%	NULL
/3	NULL
(	NULL
4	NULL
)	NULL
.	NULL

To	NULL
examine	NULL
whether	NULL
the	NULL
Y	NULL
``	NULL
**EAM	NULL
is	NULL
essential	NULL
for	NULL
the	NULL
interaction	NULL
between	NULL
Cbl	NULL
and	NULL
PI3-K	NULL
and	NULL
,	NULL
if	NULL
so	NULL
,	NULL
whether	NULL
this	NULL
association	NULL
is	NULL
required	NULL
for	NULL
the	NULL
70Z/3-mediated	NULL
NFAT	NULL
activation	NULL
,	NULL
we	NULL
mutated	NULL
the	NULL
methionine	NULL
residue	NULL
in	NULL
this	NULL
motif	NULL
of	NULL
702/83	NULL
to	NULL
cysteine	NULL
(	NULL
Y**EAC	NULL
)	NULL
.	NULL

A	NULL
similar	NULL
methionine	NULL
mutation	NULL
was	NULL
found	NULL
to	NULL
disrupt	NULL
the	NULL
association	NULL
of	NULL
the	NULL
CD28	NULL
YXXM	NULL
motif	NULL
with	NULL
PI3-K	NULL
(	NULL
87	NULL
)	NULL
.	NULL

The	NULL
relative	NULL
specificity	NULL
of	NULL
this	NULL
point	NULL
mutation	NULL
is	NULL
indicated	NULL
by	NULL
the	NULL
findings	NULL
that	NULL
:	NULL
first	NULL
,	NULL
it	NULL
did	NULL
not	NULL
have	NULL
a	NULL
global	NULL
effect	NULL
on	NULL
the	NULL
basal	NULL
or	NULL
anti-CD3-induced	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
702/83	NULL
,	NULL
as	NULL
revealed	NULL
by	NULL
anti-Tyr	NULL
(	NULL
P	NULL
)	NULL
immunoblotting	NULL
of	NULL
the	NULL
corresponding	NULL
immunoprecipitates	NULL
(	NULL
Fig	NULL
.	NULL

3C	NULL
)	NULL
;	NULL
second	NULL
,	NULL
the	NULL
mutation	NULL
did	NULL
not	NULL
appear	NULL
to	NULL
have	NULL
a	NULL
gross	NULL
effect	NULL
on	NULL
the	NULL
integrity	NULL
and/or	NULL
conformation	NULL
of	NULL
the	NULL
702/83	NULL
protein	NULL
since	NULL
it	NULL
could	NULL
still	NULL
associate	NULL
in	NULL
an	NULL
activation-independ-ent	NULL
manner	NULL
with	NULL
Grb2	NULL
(	NULL
Fig	NULL
.	NULL

3D	NULL
)	NULL
,	NULL
which	NULL
is	NULL
known	NULL
to	NULL
constitutively	NULL
associate	NULL
with	NULL
Cbl	NULL
(	NULL
5-8	NULL
)	NULL
.	NULL

Jurkat-TAg	NULL
cells	NULL
were	NULL
transiently	NULL
transfected	NULL
with	NULL
the	NULL
702/83	NULL
expression	NULL
vectors	NULL
(	NULL
or	NULL
empty	NULL
vector	NULL
)	NULL
,	NULL
and	NULL
their	NULL
association	NULL
with	NULL
endogenous	NULL
PI3-K	NULL
was	NULL
assessed	NULL
by	NULL
coimmunoprecipitation	NULL
using	NULL
the	NULL
anti-HA	NULL
tag	NULL
mAb	NULL
.	NULL

The	NULL
results	NULL
(	NULL
Fig	NULL
.	NULL

34	NULL
)	NULL
demonstrate	NULL
that	NULL
70	NULL
%	NULL
/3	NULL
coimmunoprecipitated	NULL
with	NULL
p85	NULL
in	NULL
unstimulated	NULL
cells	NULL
,	NULL
and	NULL
that	NULL
the	NULL
amount	NULL
of	NULL
coprecipitated	NULL
p85	NULL
was	NULL
markedly	NULL
increased	NULL
following	NULL
anti-CD3	NULL
stimulation	NULL
.	NULL

The	NULL
lower	NULL
association	NULL
in	NULL
unstimulated	NULL
cells	NULL
most	NULL
likely	NULL
reflects	NULL
the	NULL
basal	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
Cbl	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
very	NULL
little	NULL
association	NULL
of	NULL
Y	NULL
``	NULL
*EAC	NULL
with	NULL
PIS-K	NULL
was	NULL
observed	NULL
under	NULL
the	NULL
same	NULL
conditions	NULL
(	NULL
panel	NULL
A	NULL
)	NULL
,	NULL
although	NULL
the	NULL
expression	NULL
levels	NULL
of	NULL
the	NULL
two	NULL
Cbl	NULL
proteins	NULL
were	NULL
equivalent	NULL
as	NULL
revealed	NULL
by	NULL
anti-HA	NULL
immunoblotting	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
)	NULL
.	NULL

This	NULL
result	NULL
was	NULL
confirmed	NULL
by	NULL
performing	NULL
an	NULL
in	NULL
vitro	NULL
PI3-K	NULL
enzymatic	NULL
assay	NULL
on	NULL
the	NULL
same	NULL
immunoprecipitates	NULL
.	NULL

Thus	NULL
,	NULL
anti-HA	NULL
immunoprecipitates	NULL
from	NULL
stimulated	NULL
,	NULL
Y	NULL
``	NULL
**EAC-trans-fected	NULL
cells	NULL
contained	NULL
a	NULL
markedly	NULL
lower	NULL
PI3-K	NULL
activity	NULL
than	NULL
their	NULL
counterparts	NULL
from	NULL
70	NULL
%	NULL
/3-transfected	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

83K	NULL
)	NULL
.	NULL

To-gether	NULL
,	NULL
these	NULL
results	NULL
suggest	NULL
that	NULL
the	NULL
Y	NULL
``	NULL
**EAM	NULL
motif	NULL
in	NULL
702/83	NULL
is	NULL
largely	NULL
responsible	NULL
for	NULL
the	NULL
interaction	NULL
with	NULL
p85	NULL
.	NULL

Next	NULL
,	NULL
we	NULL
determined	NULL
the	NULL
effect	NULL
of	NULL
the	NULL
702/83	NULL
Y	NULL
``	NULL
*EAC	NULL
mutation	NULL
on	NULL
the	NULL
70Z/3-mediated	NULL
activation	NULL
of	NULL
NFAT	NULL
.	NULL

The	NULL
mutant	NULL
plasmid	NULL
or	NULL
702/83	NULL
was	NULL
cotransfected	NULL
with	NULL
the	NULL
NFAT-Lue	NULL
reporter	NULL
plasmid	NULL
into	NULL
Jurkat-TAg	NULL
T	NULL
cells	NULL
.	NULL

As	NULL
showed	NULL
in	NULL
Fig	NULL
.	NULL

4A	NULL
,	NULL
cell	NULL
lysates	NULL
from	NULL
Y'**EAC-transfected	NULL
cells	NULL
showed	NULL
1.5	NULL
to	NULL
2	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
4g	NULL
/810-0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wo	NULL
;	NULL
popeoumog	NULL
Ras-dependent	NULL
,	NULL
Ca	NULL
``	NULL
*	NULL
-stimulated	NULL
Activation	NULL
of	NULL
NFAT	NULL
171	NULL
WJ	NULL
o	NULL
L	NULL
3	NULL
m	NULL
m	NULL
&	NULL
N	NULL
a	NULL
2	NULL
E	NULL
>	NULL
-F	NULL
--	NULL
-	NULL
--	NULL
I	NULL
]	NULL
OKT3	NULL
-	NULL
+	NULL
-	NULL
+	NULL
-	NULL
+	NULL
W	NULL
M	NULL
1	NULL
®*	NULL
_	NULL
Blot	NULL
:	NULL
98-1	NULL
4	NULL
-	NULL
*	NULL
>	NULL
-	NULL
anti-p	NULL
$	NULL
5	NULL
64-102	NULL
3	NULL
4	NULL
50	NULL
6	NULL
B	NULL
ak	NULL
Blot	NULL
:	NULL
98-	NULL
o	NULL
``	NULL
*	NULL
``	NULL
=	NULL
to*	NULL
|	NULL
64-C	NULL
10	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
MW	NULL
os-	NULL
~-	NULL
sam	NULL
oe	NULL
«	NULL
am	NULL
|	NULL
Blot	NULL
:	NULL
-__	NULL
anti-Tyr	NULL
(	NULL
P	NULL
)	NULL
64-Io	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
D	NULL
MW	NULL
307	NULL
Blot	NULL
:	NULL
16-	NULL
anti-Grb2	NULL
1	NULL
2	NULL
3	NULL
4	NULL
50	NULL
6	NULL
E	NULL
*+	NULL
©	NULL
10	NULL
20	NULL
3	NULL
4	NULL
50	NULL
6	NULL
Fic	NULL
.	NULL

3	NULL
.	NULL

Mutation	NULL
of	NULL
the	NULL
Y	NULL
``	NULL
**EAM	NULL
motif	NULL
disrupts	NULL
the	NULL
association	NULL
of	NULL
702/83	NULL
with	NULL
PI3-K.	NULL
Jurkat-TAg	NULL
T	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
pEFneo	NULL
,	NULL
pEFneo-70	NULL
%	NULL
/8	NULL
,	NULL
or	NULL
pEFneo-70Z/3/Y¥	NULL
``	NULL
``	NULL
EAC	NULL
(	NULL
Y	NULL
The	NULL
cells	NULL
were	NULL
left	NULL
unstimulated	NULL
(	NULL
-	NULL
)	NULL
,	NULL
or	NULL
stimulated	NULL
(	NULL
+	NULL
)	NULL
with	NULL
an	NULL
anti-CD3	NULL
antibody	NULL
(	NULL
OKT3	NULL
)	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
then	NULL
lysed	NULL
and	NULL
Cbl	NULL
proteins	NULL
were	NULL
immu-noprecipitated	NULL
with	NULL
an	NULL
anti-HA	NULL
mAb	NULL
.	NULL

The	NULL
membrane	NULL
containing	NULL
SDS-12.5	NULL
%	NULL
polyacrylamide	NULL
gel	NULL
electrophoresis-resolved	NULL
immunoprecipitates	NULL
was	NULL
then	NULL
immunoblotted	NULL
with	NULL
an	NULL
anti-p85	NULL
antibody	NULL
(	NULL
A	NULL
)	NULL
and	NULL
reprobed	NULL
with	NULL
an	NULL
anti-HA	NULL
mAb	NULL
(	NULL
B	NULL
)	NULL
.	NULL

A	NULL
parallel	NULL
membrane	NULL
was	NULL
immunoblotted	NULL
with	NULL
an	NULL
anti-Tyr	NULL
(	NULL
P	NULL
)	NULL
mAb	NULL
(	NULL
C	NULL
)	NULL
,	NULL
followed	NULL
by	NULL
reprobing	NULL
with	NULL
an	NULL
anti-Grb2	NULL
mAb	NULL
(	NULL
D	NULL
)	NULL
.	NULL

The	NULL
positions	NULL
of	NULL
molecular	NULL
mass	NULL
(	NULL
MW	NULL
)	NULL
standards	NULL
are	NULL
indicated	NULL
(	NULL
X	NULL
1000	NULL
)	NULL
.	NULL

Aliquots	NULL
of	NULL
the	NULL
same	NULL
immunoprecipitates	NULL
were	NULL
also	NULL
analyzed	NULL
for	NULL
PIS-K	NULL
activity	NULL
by	NULL
thin-layer	NULL
chromatography	NULL
(	NULL
E	NULL
)	NULL
.	NULL

The	NULL
arrow	NULL
indicates	NULL
the	NULL
position	NULL
of	NULL
phosphatidylinositol	NULL
3-phosphate	NULL
(	NULL
PI	NULL
(	NULL
3	NULL
)	NULL
P	NULL
)	NULL
.	NULL

times	NULL
higher	NULL
luciferase	NULL
activity	NULL
both	NULL
in	NULL
resting	NULL
and	NULL
ionomycin-stimulated	NULL
cells	NULL
than	NULL
that	NULL
from	NULL
702/3-transfected	NULL
cells	NULL
.	NULL

Similar	NULL
results	NULL
were	NULL
consistently	NULL
observed	NULL
in	NULL
a	NULL
number	NULL
of	NULL
repeated	NULL
experiments	NULL
.	NULL

The	NULL
expression	NULL
levels	NULL
of	NULL
the	NULL
transfected	NULL
plasmids	NULL
were	NULL
determined	NULL
by	NULL
immunoblotting	NULL
and	NULL
no	NULL
apparent	NULL
difference	NULL
was	NULL
detected	NULL
between	NULL
702/3	NULL
and	NULL
Y	NULL
``	NULL
**EAC	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
)	NULL
.	NULL

These	NULL
data	NULL
strongly	NULL
suggest	NULL
that	NULL
an	NULL
optimal	NULL
interaction	NULL
between	NULL
PI3-K	NULL
and	NULL
702/83	NULL
is	NULL
not	NULL
required	NULL
for	NULL
NFAT	NULL
activity	NULL
induced	NULL
by	NULL
the	NULL
latter	NULL
.	NULL

The	NULL
Effects	NULL
of	NULL
C-terminal	NULL
Deletions	NULL
on	NULL
70Z	NULL
%	NULL
/3-mediated	NULL
NFAT	NULL
Activation-In	NULL
order	NULL
to	NULL
further	NULL
define	NULL
the	NULL
region	NULL
in	NULL
702/83	NULL
which	NULL
is	NULL
responsible	NULL
for	NULL
NFAT	NULL
activation	NULL
,	NULL
we	NULL
focused	NULL
on	NULL
the	NULL
C-terminal	NULL
region	NULL
of	NULL
the	NULL
protein	NULL
,	NULL
since	NULL
v-Cbl	NULL
,	NULL
which	NULL
corresponds	NULL
to	NULL
the	NULL
361	NULL
N-terminal	NULL
residues	NULL
of	NULL
human	NULL
c-Cbl	NULL
,	NULL
lacked	NULL
any	NULL
NFAT-stimulating	NULL
activity	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

The	NULL
C-terminal	NULL
region	NULL
of	NULL
c-Cbl	NULL
contains	NULL
a	NULL
proline-rich	NULL
region	NULL
and	NULL
several	NULL
potential	NULL
tyrosine	NULL
phosphorylation	NULL
sites	NULL
(	NULL
2	NULL
)	NULL
.	NULL

Expression	NULL
vectors	NULL
encoding	NULL
A	NULL
20	NULL
O	NULL
pEFneo	NULL
C	NULL
E	NULL
In	NULL
1	NULL
Relative	NULL
Luc	NULL
Activity	NULL
5	NULL
1	NULL
a	NULL
1	NULL
9	NULL
-_-	NULL
-G	NULL
control	NULL
ionomycin	NULL
|_	NULL
PMA	NULL
Stimulation	NULL
B	NULL
y	NULL
o	NULL
<	NULL
C	NULL
$	NULL
oa	NULL
a	NULL
&	NULL
N	NULL
a	NULL
&	NULL
t	NULL
>	NULL
8	NULL
E	NULL
>	NULL
esse	NULL
asm	NULL
»	NULL
|	NULL
Blot	NULL
:	NULL
anti-HA	NULL
Fig	NULL
.	NULL

4	NULL
.	NULL

NFAT	NULL
activation	NULL
by	NULL
702/83	NULL
is	NULL
independent	NULL
of	NULL
PIS-K	NULL
asso-ciation	NULL
.	NULL

A	NULL
,	NULL
Jurkat-TAg	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
NFAT-Lue	NULL
plus	NULL
pEFneo	NULL
,	NULL
pEFneo70Z/3	NULL
,	NULL
or	NULL
pEFneo/Y'**EAC	NULL
(	NULL
Y	NULL
*EAC	NULL
)	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
left	NULL
unstimulated	NULL
or	NULL
stimulated	NULL
as	NULL
indicated	NULL
,	NULL
and	NULL
lysates	NULL
were	NULL
then	NULL
assayed	NULL
for	NULL
luciferase	NULL
activity	NULL
.	NULL

Bars	NULL
represent	NULL
the	NULL
mean	NULL
of	NULL
triplicate	NULL
samples	NULL
.	NULL

The	NULL
data	NULL
shown	NULL
are	NULL
representative	NULL
of	NULL
six	NULL
experiments	NULL
.	NULL

B	NULL
,	NULL
cell	NULL
lysates	NULL
were	NULL
analyzed	NULL
for	NULL
the	NULL
expression	NULL
levels	NULL
of	NULL
the	NULL
Chl	NULL
proteins	NULL
by	NULL
immunoblotting	NULL
with	NULL
an	NULL
anti-HA	NULL
mAb	NULL
.	NULL

70Z/3	NULL
proteins	NULL
with	NULL
successive	NULL
C-terminal	NULL
deletions	NULL
were	NULL
generated	NULL
(	NULL
Fig	NULL
.	NULL

5A	NULL
)	NULL
and	NULL
assessed	NULL
for	NULL
their	NULL
ability	NULL
to	NULL
activate	NULL
NFAT	NULL
in	NULL
Jurkat-TAg	NULL
cells	NULL
by	NULL
transient	NULL
cotransfection	NULL
assays	NULL
(	NULL
Fig	NULL
.	NULL

5B	NULL
)	NULL
.	NULL

As	NULL
shown	NULL
earlier	NULL
(	NULL
Figs	NULL
.	NULL

1	NULL
and	NULL
2	NULL
)	NULL
,	NULL
70	NULL
%	NULL
/3	NULL
caused	NULL
a	NULL
~3-fold	NULL
increase	NULL
in	NULL
the	NULL
basal	NULL
NFAT	NULL
activity	NULL
and	NULL
stimulated	NULL
it	NULL
by	NULL
~70-fold	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
ionomycin	NULL
,	NULL
whereas	NULL
v-Cbl	NULL
was	NULL
inactive	NULL
.	NULL

Similarly	NULL
,	NULL
mutation	NULL
of	NULL
the	NULL
major	NULL
PI3-K-binding	NULL
motif	NULL
(	NULL
Y¥	NULL
``	NULL
*	NULL
``	NULL
EAC	NULL
)	NULL
caused	NULL
some	NULL
increase	NULL
in	NULL
the	NULL
corresponding	NULL
activity	NULL
.	NULL

Deletion	NULL
of	NULL
114	NULL
or	NULL
176	NULL
C-terminal	NULL
residues	NULL
(	NULL
A1	NULL
and	NULL
A2	NULL
,	NULL
respec-tively	NULL
)	NULL
reduced	NULL
the	NULL
activity	NULL
by	NULL
~50	NULL
%	NULL
relative	NULL
to	NULL
the	NULL
untruncated	NULL
70	NULL
%	NULL
/3	NULL
.	NULL

These	NULL
results	NULL
suggest	NULL
that	NULL
the	NULL
C-terminal	NULL
114	NULL
amino	NULL
acids	NULL
of	NULL
702/38	NULL
contribute	NULL
to	NULL
maximal	NULL
NFAT	NULL
activation	NULL
.	NULL

Surprisingly	NULL
,	NULL
the	NULL
A3	NULL
construct	NULL
,	NULL
in	NULL
which	NULL
the	NULL
346	NULL
C-terminal	NULL
70Z/3	NULL
residues	NULL
have	NULL
been	NULL
deleted	NULL
,	NULL
induced	NULL
higher	NULL
basal	NULL
or	NULL
ionomycin-stimulated	NULL
NFAT	NULL
activity	NULL
than	NULL
the	NULL
untruncated	NULL
70Z/3	NULL
construct	NULL
,	NULL
and	NULL
deletion	NULL
of	NULL
additional	NULL
20	NULL
(	NULL
A4	NULL
)	NULL
or	NULL
110	NULL
(	NULL
A5	NULL
)	NULL
residues	NULL
essentially	NULL
abolished	NULL
this	NULL
activity	NULL
(	NULL
Fig	NULL
.	NULL

5B	NULL
)	NULL
.	NULL

The	NULL
differences	NULL
in	NULL
biological	NULL
activity	NULL
among	NULL
the	NULL
distinct	NULL
702/83	NULL
constructs	NULL
did	NULL
not	NULL
reflect	NULL
differences	NULL
in	NULL
their	NULL
expression	NULL
levels	NULL
since	NULL
immunoblotting	NULL
lysates	NULL
of	NULL
the	NULL
transiently	NULL
transfected	NULL
cells	NULL
with	NULL
an	NULL
anti-HA	NULL
tag	NULL
antibody	NULL
revealed	NULL
similar	NULL
expression	NULL
levels	NULL
of	NULL
the	NULL
corresponding	NULL
proteins	NULL
(	NULL
Fig	NULL
.	NULL

5C	NULL
)	NULL
.	NULL

A	NULL
Functional	NULL
Ras	NULL
Is	NULL
Required	NULL
for	NULL
the	NULL
70Z/3	NULL
Function-The	NULL
finding	NULL
that	NULL
70Z2/3	NULL
synergizes	NULL
with	NULL
ionomycin	NULL
to	NULL
induce	NULL
NFAT	NULL
activation	NULL
was	NULL
reminiscent	NULL
of	NULL
the	NULL
effect	NULL
of	NULL
constitutively	NULL
active	NULL
Ras	NULL
which	NULL
can	NULL
also	NULL
cooperate	NULL
with	NULL
ionomycin	NULL
to	NULL
induce	NULL
NFAT	NULL
or	NULL
IL2	NULL
promoter	NULL
activity	NULL
(	NULL
40-43	NULL
)	NULL
.	NULL

To	NULL
examine	NULL
whether	NULL
NFAT	NULL
activation	NULL
by	NULL
702/38	NULL
is	NULL
dependent	NULL
on	NULL
functional	NULL
Ras	NULL
,	NULL
we	NULL
cotransfected	NULL
Jurkat-TAg	NULL
cells	NULL
with	NULL
combinations	NULL
of	NULL
70/3	NULL
and/or	NULL
a	NULL
dominant	NULL
negative	NULL
Ras	NULL
expression	NULL
vector	NULL
(	NULL
or	NULL
with	NULL
the	NULL
corresponding	NULL
empty	NULL
vectors	NULL
)	NULL
,	NULL
and	NULL
assessed	NULL
the	NULL
degree	NULL
of	NULL
NFAT	NULL
activation	NULL
.	NULL

The	NULL
70	NULL
%	NULL
/3-induced	NULL
NFAT	NULL
activation	NULL
was	NULL
nearly	NULL
completely	NULL
inhibited	NULL
by	NULL
RasN17	NULL
in	NULL
either	NULL
resting	NULL
or	NULL
ionomycin	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
4g	NULL
/810-0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wo	NULL
;	NULL
popeoumog	NULL
172	NULL
Ras-dependent	NULL
,	NULL
Ca	NULL
``	NULL
*	NULL
-stimulated	NULL
Activation	NULL
of	NULL
NFAT	NULL
A	NULL
Rinﬁﬁnger	NULL
70273	NULL
#	NULL
¥	NULL
``	NULL
}	NULL
'rac	NULL
17	NULL
aa	NULL
deletion	NULL
tn	NULL
1	NULL
10	NULL
-	NULL
]	NULL
ORI	NULL
MOEA	NULL
z	NULL
Relative	NULL
Lue	NULL
Activity	NULL
t	NULL
1	NULL
remi	NULL
control	NULL
ionomycin	NULL
Stimulation	NULL
vicbl	NULL
MW	NULL
og	NULL
.	NULL

_-64-	NULL
t	NULL
>	NULL
#	NULL
0	NULL
a	NULL
an	NULL
50-	NULL
woe	NULL
Fic	NULL
.	NULL

5	NULL
.	NULL

Effects	NULL
of	NULL
C-terminal	NULL
deletions	NULL
on	NULL
the	NULL
NFAT-inducing	NULL
activity	NULL
of	NULL
702/83	NULL
.	NULL

A	NULL
,	NULL
schematic	NULL
illustration	NULL
of	NULL
the	NULL
70Z/3	NULL
constructs	NULL
.	NULL

All	NULL
the	NULL
constructs	NULL
contain	NULL
an	NULL
HA	NULL
tag	NULL
epitope	NULL
at	NULL
the	NULL
N	NULL
terminus	NULL
(	NULL
star	NULL
)	NULL
.	NULL

Shown	NULL
are	NULL
the	NULL
17-amino	NULL
acid	NULL
deletion	NULL
occurring	NULL
near	NULL
the	NULL
zinc	NULL
Ring	NULL
finger	NULL
of	NULL
c-Cbl	NULL
which	NULL
led	NULL
to	NULL
the	NULL
generation	NULL
of	NULL
702/83	NULL
,	NULL
the	NULL
11	NULL
proline-rich	NULL
stretches	NULL
in	NULL
the	NULL
C-terminal	NULL
region	NULL
of	NULL
human	NULL
Cbl	NULL
(	NULL
black	NULL
bars	NULL
)	NULL
,	NULL
and	NULL
the	NULL
position	NULL
of	NULL
the	NULL
Y	NULL
``	NULL
**EAC	NULL
point	NULL
mutation	NULL
(	NULL
asterisk	NULL
)	NULL
.	NULL

The	NULL
numbers	NULL
of	NULL
the	NULL
last	NULL
amino	NULL
acid	NULL
residue	NULL
in	NULL
each	NULL
construct	NULL
are	NULL
indicated	NULL
with	NULL
respect	NULL
to	NULL
the	NULL
original	NULL
c-Cbl	NULL
sequence	NULL
.	NULL

The	NULL
v-Cbl	NULL
construct	NULL
encoding	NULL
the	NULL
N-terminal	NULL
361	NULL
amino	NULL
acids	NULL
of	NULL
c-Cbl	NULL
is	NULL
also	NULL
shown	NULL
.	NULL

B	NULL
,	NULL
Jurkat-TAg	NULL
T	NULL
cells	NULL
were	NULL
transiently	NULL
cotransfected	NULL
with	NULL
an	NULL
NFAT-luc	NULL
reporter	NULL
plasmid	NULL
plus	NULL
the	NULL
indicated	NULL
Cbl	NULL
expression	NULL
plasmids	NULL
.	NULL

Cells	NULL
were	NULL
cultured	NULL
in	NULL
the	NULL
absence	NULL
or	NULL
presence	NULL
of	NULL
ionomycin	NULL
(	NULL
100	NULL
ng/ml	NULL
)	NULL
for	NULL
the	NULL
final	NULL
8-10	NULL
h	NULL
of	NULL
culture	NULL
and	NULL
then	NULL
assayed	NULL
for	NULL
luciferase	NULL
activity	NULL
.	NULL

C	NULL
,	NULL
the	NULL
cell	NULL
lysates	NULL
were	NULL
analyzed	NULL
for	NULL
expression	NULL
of	NULL
the	NULL
transfected	NULL
Cbl	NULL
proteins	NULL
by	NULL
immunoblotting	NULL
with	NULL
an	NULL
anti-HA	NULL
antibody	NULL
.	NULL

Molecular	NULL
weight	NULL
(	NULL
MW	NULL
)	NULL
standards	NULL
are	NULL
shown	NULL
(	NULL
X	NULL
100	NULL
)	NULL
.	NULL

stimulated	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

6A	NULL
)	NULL
.	NULL

The	NULL
expression	NULL
level	NULL
of	NULL
70	NULL
%	NULL
/3	NULL
was	NULL
,	NULL
however	NULL
,	NULL
similar	NULL
in	NULL
cells	NULL
cotransfected	NULL
with	NULL
the	NULL
control	NULL
(	NULL
pcDNA3	NULL
)	NULL
or	NULL
RasN17	NULL
expression	NULL
vector	NULL
(	NULL
Fig	NULL
.	NULL

6B	NULL
)	NULL
.	NULL

These	NULL
results	NULL
suggest	NULL
that	NULL
functional	NULL
Ras	NULL
is	NULL
required	NULL
for	NULL
the	NULL
70Z2/3-mediated	NULL
activation	NULL
of	NULL
NFAT	NULL
.	NULL

DISCUSSION	NULL
In	NULL
the	NULL
present	NULL
study	NULL
,	NULL
we	NULL
have	NULL
demonstrated	NULL
that	NULL
702/3	NULL
,	NULL
a	NULL
mutated	NULL
version	NULL
of	NULL
the	NULL
Cbl	NULL
protooncogene	NULL
product	NULL
,	NULL
but	NULL
not	NULL
wild-type	NULL
Cbl	NULL
or	NULL
v-Cbl	NULL
,	NULL
functions	NULL
in	NULL
a	NULL
constitutively	NULL
active	NULL
manner	NULL
to	NULL
induce	NULL
NFAT	NULL
activation	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
and	NULL
,	NULL
furthermore	NULL
,	NULL
that	NULL
702/83	NULL
acts	NULL
in	NULL
synergy	NULL
with	NULL
calcium	NULL
ionophore	NULL
in	NULL
this	NULL
regard	NULL
.	NULL

Cyclosporin	NULL
A	NULL
,	NULL
which	NULL
selectively	NULL
inhibits	NULL
the	NULL
function	NULL
of	NULL
calcineurin	NULL
(	NULL
35	NULL
,	NULL
36	NULL
)	NULL
,	NULL
as	NULL
well	NULL
as	NULL
dominant	NULL
negative	NULL
Ras	NULL
,	NULL
blocked	NULL
A	NULL
[	NULL
D	NULL
]	NULL
pEFneo/peDNA3	NULL
[	NULL
C	NULL
_|	NULL
pEFneo/RasN17	NULL
70Z/3/RasN17	NULL
107	NULL
Relative	NULL
Luc	NULL
activity	NULL
control	NULL
ionomycin	NULL
Stimulation	NULL
B	NULL
peDNA3	NULL
RasN17	NULL
r	NULL
ts	NULL
g	NULL
&	NULL
F	NULL
©	NULL
|	NULL
S	NULL
3	NULL
s	NULL
_C	NULL
isd	NULL
MW	NULL
98	NULL
Fic	NULL
.	NULL

6	NULL
.	NULL

Induction	NULL
of	NULL
NFAT	NULL
by	NULL
702/83	NULL
requires	NULL
functional	NULL
Ras	NULL
.	NULL

A	NULL
,	NULL
Jurkat-TAg	NULL
T	NULL
cells	NULL
were	NULL
cotransfected	NULL
with	NULL
the	NULL
NFAT-Luc	NULL
reporter	NULL
plasmid	NULL
plus	NULL
pEFneo	NULL
or	NULL
pEFneo-70Z/3	NULL
together	NULL
with	NULL
empty	NULL
peDNA8	NULL
vector	NULL
or	NULL
pcDNAS-RasN17	NULL
.	NULL

Transfected	NULL
cells	NULL
were	NULL
left	NULL
unstimulated	NULL
or	NULL
stimulated	NULL
with	NULL
ionomycin	NULL
,	NULL
and	NULL
lysed	NULL
for	NULL
the	NULL
luciferase	NULL
assay	NULL
.	NULL

Bars	NULL
represents	NULL
the	NULL
mean	NULL
of	NULL
triplicate	NULL
samples	NULL
.	NULL

The	NULL
data	NULL
shown	NULL
are	NULL
representative	NULL
of	NULL
three	NULL
experiments	NULL
.	NULL

B	NULL
,	NULL
samples	NULL
of	NULL
the	NULL
same	NULL
lysates	NULL
were	NULL
analyzed	NULL
for	NULL
70Z/3	NULL
expression	NULL
by	NULL
immunoblotting	NULL
with	NULL
an	NULL
anti-HA	NULL
mAb	NULL
.	NULL

A	NULL
molecular	NULL
weight	NULL
(	NULL
MW	NULL
)	NULL
standard	NULL
is	NULL
shown	NULL
(	NULL
X	NULL
1000	NULL
)	NULL
.	NULL

both	NULL
the	NULL
basal	NULL
and	NULL
the	NULL
ionomycin-stimulated	NULL
induction	NULL
of	NULL
NFAT	NULL
by	NULL
702/83	NULL
.	NULL

On	NULL
the	NULL
other	NULL
hand	NULL
,	NULL
a	NULL
mutation	NULL
that	NULL
markedly	NULL
reduced	NULL
the	NULL
association	NULL
of	NULL
702/83	NULL
with	NULL
PI3-K	NULL
did	NULL
not	NULL
impair	NULL
the	NULL
activation	NULL
of	NULL
NFAT	NULL
and	NULL
,	NULL
in	NULL
fact	NULL
,	NULL
seemed	NULL
to	NULL
increase	NULL
it	NULL
.	NULL

These	NULL
results	NULL
suggest	NULL
that	NULL
Cbl	NULL
is	NULL
involved	NULL
in	NULL
the	NULL
TCR-CD3-mediated	NULL
signaling	NULL
pathway	NULL
(	NULL
s	NULL
)	NULL
which	NULL
ultimately	NULL
lead	NULL
to	NULL
the	NULL
activation	NULL
of	NULL
NFAT	NULL
,	NULL
one	NULL
of	NULL
the	NULL
critical	NULL
transcription	NULL
factor	NULL
complexes	NULL
involved	NULL
in	NULL
induction	NULL
of	NULL
IL2	NULL
and	NULL
other	NULL
cytokine	NULL
genes	NULL
(	NULL
31	NULL
,	NULL
32	NULL
)	NULL
.	NULL

Optimal	NULL
activation	NULL
of	NULL
NFAT	NULL
and	NULL
the	NULL
IL2	NULL
promoter	NULL
requires	NULL
two	NULL
signals	NULL
which	NULL
can	NULL
be	NULL
mimicked	NULL
by	NULL
agents	NULL
that	NULL
increase	NULL
the	NULL
free	NULL
intracellular	NULL
calcium	NULL
concentration	NULL
and	NULL
activate	NULL
the	NULL
protein	NULL
kinase	NULL
C/Ras	NULL
pathway	NULL
in	NULL
T	NULL
cells	NULL
,	NULL
respectively	NULL
(	NULL
40-43	NULL
)	NULL
.	NULL

Constitutively	NULL
active	NULL
calcineurin	NULL
,	NULL
which	NULL
can	NULL
replace	NULL
the	NULL
calcium	NULL
signal	NULL
,	NULL
or	NULL
ionomycin	NULL
,	NULL
can	NULL
each	NULL
synergize	NULL
with	NULL
phorbol	NULL
ester	NULL
or	NULL
constitutively	NULL
active	NULL
Ras	NULL
to	NULL
induce	NULL
NFAT	NULL
activation	NULL
(	NULL
41	NULL
,	NULL
42	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
calcineurin	NULL
is	NULL
a	NULL
major	NULL
target	NULL
for	NULL
the	NULL
calcium	NULL
signal	NULL
involved	NULL
in	NULL
NFAT	NULL
activation	NULL
and	NULL
IL2	NULL
gene	NULL
transcription	NULL
.	NULL

Our	NULL
finding	NULL
that	NULL
702/38	NULL
synergized	NULL
with	NULL
ionomycin	NULL
(	NULL
but	NULL
not	NULL
with	NULL
PMA	NULL
)	NULL
to	NULL
induce	NULL
NFAT	NULL
activation	NULL
,	NULL
and	NULL
that	NULL
this	NULL
effect	NULL
was	NULL
blocked	NULL
by	NULL
cyclosporin	NULL
A	NULL
pretreatment	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
,	NULL
strongly	NULL
sug-gest	NULL
,	NULL
therefore	NULL
,	NULL
that	NULL
this	NULL
constitutively	NULL
active	NULL
Cbl	NULL
can	NULL
cooperate	NULL
with	NULL
calcineurin	NULL
to	NULL
provide	NULL
the	NULL
requisite	NULL
signals	NULL
for	NULL
NFAT	NULL
activation	NULL
.	NULL

70Z2/3	NULL
mimicks	NULL
in	NULL
this	NULL
respect	NULL
the	NULL
effects	NULL
of	NULL
constitutively	NULL
active	NULL
Ras	NULL
(	NULL
41	NULL
,	NULL
42	NULL
)	NULL
.	NULL

The	NULL
similarity	NULL
with	NULL
Ras	NULL
also	NULL
extends	NULL
to	NULL
the	NULL
finding	NULL
that	NULL
,	NULL
like	NULL
Ras	NULL
(	NULL
41	NULL
,	NULL
42	NULL
)	NULL
,	NULL
70	NULL
%	NULL
/3	NULL
synergized	NULL
with	NULL
ionomycin	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
,	NULL
but	NULL
not	NULL
with	NULL
an	NULL
anti-CD3	NULL
mAb	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
to	NULL
activate	NULL
NFAT	NULL
.	NULL

This	NULL
connection	NULL
between	NULL
Cbl	NULL
and	NULL
the	NULL
Ras	NULL
signaling	NULL
pathway	NULL
is	NULL
supported	NULL
by	NULL
our	NULL
finding	NULL
that	NULL
dominant	NULL
negative	NULL
Ras	NULL
inhibited	NULL
almost	NULL
completely	NULL
the	NULL
702/3-induced	NULL
activation	NULL
of	NULL
NFAT	NULL
,	NULL
indicating	NULL
that	NULL
functional	NULL
Ras	NULL
is	NULL
necessary	NULL
for	NULL
NFAT	NULL
induction	NULL
in	NULL
the	NULL
context	NULL
of	NULL
702/38	NULL
.	NULL

This	NULL
finding	NULL
does	NULL
not	NULL
allow	NULL
us	NULL
to	NULL
conclude	NULL
at	NULL
present	NULL
whether	NULL
Ras	NULL
acts	NULL
downstream	NULL
of	NULL
702/83	NULL
,	NULL
or	NULL
in	NULL
a	NULL
parallel	NULL
pathway	NULL
which	NULL
interacts	NULL
with	NULL
a	NULL
Cbl-dependent	NULL
pathway	NULL
,	NULL
to	NULL
induce	NULL
NFAT	NULL
activation	NULL
.	NULL

610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
4g	NULL
/810-0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wo	NULL
;	NULL
popeoumog	NULL
Ras-dependent	NULL
,	NULL
Ca	NULL
``	NULL
*	NULL
-stimulated	NULL
Activation	NULL
of	NULL
NFAT	NULL
Recent	NULL
studies	NULL
have	NULL
indicated	NULL
that	NULL
,	NULL
in	NULL
hematopoietic	NULL
(	NULL
5	NULL
,	NULL
6	NULL
,	NULL
17	NULL
)	NULL
and	NULL
other	NULL
(	NULL
13	NULL
)	NULL
cells	NULL
,	NULL
tyrosine-phosphorylated	NULL
Cbl	NULL
recruits	NULL
PI3-K	NULL
,	NULL
an	NULL
interaction	NULL
that	NULL
may	NULL
be	NULL
mediated	NULL
by	NULL
tyrosine-con-taining	NULL
YXXM	NULL
motifs	NULL
in	NULL
Cbl	NULL
and	NULL
the	NULL
SH2	NULL
domain	NULL
of	NULL
p85	NULL
(	NULL
17	NULL
)	NULL
.	NULL

Since	NULL
PI3-K	NULL
may	NULL
be	NULL
involved	NULL
in	NULL
signaling	NULL
pathways	NULL
leading	NULL
to	NULL
IL2	NULL
production	NULL
(	NULL
37	NULL
,	NULL
38	NULL
)	NULL
,	NULL
it	NULL
was	NULL
of	NULL
interest	NULL
to	NULL
examine	NULL
whether	NULL
PI3-K	NULL
association	NULL
with	NULL
Cbl	NULL
is	NULL
required	NULL
in	NULL
order	NULL
for	NULL
702/83	NULL
to	NULL
activate	NULL
NFAT	NULL
.	NULL

We	NULL
found	NULL
that	NULL
a	NULL
point	NULL
mutation	NULL
of	NULL
methionine	NULL
to	NULL
cysteine	NULL
in	NULL
the	NULL
Y	NULL
``	NULL
**EAM	NULL
motif	NULL
of	NULL
702/83	NULL
reduced	NULL
the	NULL
association	NULL
of	NULL
702	NULL
%	NULL
/3	NULL
with	NULL
PI3-K	NULL
to	NULL
a	NULL
minimum	NULL
,	NULL
indicating	NULL
that	NULL
this	NULL
motif	NULL
is	NULL
largely	NULL
responsible	NULL
for	NULL
the	NULL
interaction	NULL
of	NULL
702/83	NULL
with	NULL
PI3-K	NULL
.	NULL

However	NULL
,	NULL
this	NULL
mutation	NULL
increased	NULL
the	NULL
activation	NULL
of	NULL
NFAT	NULL
by	NULL
702/83	NULL
,	NULL
suggesting	NULL
that	NULL
activation-dependent	NULL
recruitment	NULL
of	NULL
PI3-K	NULL
to	NULL
Chl	NULL
is	NULL
not	NULL
required	NULL
for	NULL
the	NULL
induction	NULL
of	NULL
NFAT	NULL
.	NULL

A	NULL
striking	NULL
observation	NULL
in	NULL
the	NULL
present	NULL
study	NULL
is	NULL
that	NULL
the	NULL
702/83	NULL
A3	NULL
mutant	NULL
,	NULL
from	NULL
which	NULL
346	NULL
C-terminal	NULL
amino	NULL
acid	NULL
residues	NULL
were	NULL
deleted	NULL
,	NULL
exhibited	NULL
the	NULL
highest	NULL
NFAT-inducing	NULL
transcriptional	NULL
activity	NULL
.	NULL

Further	NULL
deletion	NULL
of	NULL
only	NULL
20	NULL
additional	NULL
amino	NULL
acid	NULL
residues	NULL
(	NULL
A4	NULL
)	NULL
completely	NULL
abrogated	NULL
basal	NULL
or	NULL
ionomycin-stimulated	NULL
NFAT	NULL
induction	NULL
.	NULL

One	NULL
potential	NULL
explanation	NULL
is	NULL
that	NULL
the	NULL
region	NULL
represented	NULL
by	NULL
residues	NULL
541-560	NULL
in	NULL
70	NULL
%	NULL
/3	NULL
interacts	NULL
directly	NULL
or	NULL
indirectly	NULL
with	NULL
an	NULL
essential	NULL
effector	NULL
involved	NULL
in	NULL
NFAT	NULL
activation	NULL
,	NULL
and	NULL
that	NULL
removal	NULL
of	NULL
more	NULL
proximal	NULL
residues	NULL
(	NULL
i.e	NULL
.	NULL

residues	NULL
561-906	NULL
)	NULL
facilitates	NULL
this	NULL
interaction	NULL
,	NULL
perhaps	NULL
by	NULL
abolishing	NULL
other	NULL
interactions	NULL
with	NULL
a	NULL
negative	NULL
regulator	NULL
(	NULL
s	NULL
)	NULL
.	NULL

Al-ternatively	NULL
,	NULL
differences	NULL
in	NULL
biological	NULL
activity	NULL
among	NULL
the	NULL
various	NULL
constructs	NULL
represent	NULL
conformational	NULL
changes	NULL
in	NULL
the	NULL
structure	NULL
of	NULL
702/38	NULL
,	NULL
in	NULL
which	NULL
case	NULL
A3	NULL
may	NULL
have	NULL
a	NULL
more	NULL
favorable	NULL
conformation	NULL
for	NULL
mediating	NULL
the	NULL
effector	NULL
function	NULL
of	NULL
Cbl	NULL
.	NULL

Since	NULL
the	NULL
70Z/3	NULL
deletions	NULL
remove	NULL
distinct	NULL
proline-rich	NULL
sequences	NULL
which	NULL
have	NULL
been	NULL
implicated	NULL
in	NULL
binding	NULL
to	NULL
SH3	NULL
domains	NULL
of	NULL
other	NULL
proteins	NULL
(	NULL
5-8	NULL
,	NULL
44	NULL
)	NULL
,	NULL
it	NULL
is	NULL
possible	NULL
that	NULL
interactions	NULL
with	NULL
SHS-containing	NULL
signaling	NULL
proteins	NULL
are	NULL
a	NULL
major	NULL
target	NULL
for	NULL
the	NULL
functional	NULL
effects	NULL
of	NULL
these	NULL
deletions	NULL
.	NULL

This	NULL
possibility	NULL
is	NULL
currently	NULL
being	NULL
analyzed	NULL
.	NULL

What	NULL
is	NULL
the	NULL
molecular	NULL
mechanism	NULL
by	NULL
which	NULL
the	NULL
constitutively	NULL
active	NULL
Cbl	NULL
mutant	NULL
,	NULL
702/83	NULL
,	NULL
affects	NULL
the	NULL
transcriptional	NULL
regulation	NULL
of	NULL
NFAT	NULL
?	NULL

The	NULL
finding	NULL
that	NULL
702/3	NULL
,	NULL
but	NULL
not	NULL
wild-type	NULL
Cbl	NULL
,	NULL
can	NULL
mediate	NULL
this	NULL
event	NULL
suggests	NULL
that	NULL
amino	NULL
acid	NULL
residues	NULL
366-383	NULL
(	NULL
which	NULL
have	NULL
been	NULL
deleted	NULL
in	NULL
702/83	NULL
)	NULL
regulate	NULL
negatively	NULL
the	NULL
function	NULL
of	NULL
Cbl	NULL
or	NULL
its	NULL
association	NULL
with	NULL
effector	NULL
proteins	NULL
,	NULL
and	NULL
that	NULL
their	NULL
removal	NULL
unmasks	NULL
the	NULL
ability	NULL
of	NULL
Cbl	NULL
to	NULL
activate	NULL
NFAT	NULL
.	NULL

This	NULL
is	NULL
compatible	NULL
with	NULL
the	NULL
findings	NULL
that	NULL
the	NULL
same	NULL
deletion	NULL
activates	NULL
the	NULL
transforming	NULL
potential	NULL
of	NULL
Cbl	NULL
(	NULL
4	NULL
)	NULL
.	NULL

The	NULL
notion	NULL
of	NULL
a	NULL
negative	NULL
regulatory	NULL
activity	NULL
associated	NULL
with	NULL
Cbl	NULL
is	NULL
supported	NULL
by	NULL
the	NULL
recent	NULL
finding	NULL
that	NULL
a	NULL
Cbl	NULL
homologue	NULL
,	NULL
Sli-1	NULL
,	NULL
negatively	NULL
regulates	NULL
vulval	NULL
development	NULL
in	NULL
Caenorhabditis	NULL
el-egans	NULL
,	NULL
a	NULL
process	NULL
which	NULL
is	NULL
known	NULL
to	NULL
be	NULL
initiated	NULL
by	NULL
a	NULL
homologue	NULL
of	NULL
the	NULL
epidermal	NULL
growth	NULL
factor	NULL
receptor	NULL
via	NULL
a	NULL
tyrosine	NULL
kinase-and	NULL
Ras-dependent	NULL
signaling	NULL
pathway	NULL
(	NULL
45	NULL
)	NULL
.	NULL

The	NULL
internal	NULL
deletion	NULL
may	NULL
activate	NULL
Cbl	NULL
directly	NULL
,	NULL
or	NULL
indirectly	NULL
by	NULL
abolishing	NULL
an	NULL
interaction	NULL
between	NULL
Chl	NULL
and	NULL
a	NULL
putative	NULL
negative	NULL
regulator	NULL
that	NULL
binds	NULL
to	NULL
the	NULL
deleted	NULL
region	NULL
.	NULL

It	NULL
is	NULL
possible	NULL
that	NULL
this	NULL
activity	NULL
can	NULL
also	NULL
be	NULL
unmasked	NULL
by	NULL
an	NULL
undefined	NULL
physiological	NULL
signal	NULL
which	NULL
leads	NULL
to	NULL
Cbl	NULL
activation	NULL
during	NULL
T	NULL
cell	NULL
activation	NULL
.	NULL

In	NULL
any	NULL
event	NULL
,	NULL
recent	NULL
findings	NULL
that	NULL
Cbl	NULL
functions	NULL
as	NULL
an	NULL
adapter	NULL
protein	NULL
and	NULL
associates	NULL
with	NULL
many	NULL
signaling	NULL
proteins	NULL
suggest	NULL
that	NULL
Cbl-asso-ciated	NULL
proteins	NULL
may	NULL
act	NULL
as	NULL
intermediate	NULL
effectors	NULL
to	NULL
transduce	NULL
signals	NULL
from	NULL
Chl	NULL
which	NULL
lead	NULL
to	NULL
induction	NULL
of	NULL
NFAT	NULL
,	NULL
and	NULL
perhaps	NULL
other	NULL
transcriptional	NULL
elements	NULL
involved	NULL
in	NULL
T	NULL
cell	NULL
activation	NULL
.	NULL

Our	NULL
findings	NULL
open	NULL
the	NULL
way	NULL
for	NULL
further	NULL
studies	NULL
to	NULL
directly	NULL
investigate	NULL
the	NULL
mechanism	NULL
by	NULL
which	NULL
Cbl	NULL
acts	NULL
to	NULL
regulate	NULL
signaling	NULL
pathways	NULL
initiated	NULL
by	NULL
immune	NULL
recognition	NULL
receptors	NULL
.	NULL

10	NULL
.	NULL

11	NULL
.	NULL

12.	NULL
.	NULL

Soltoff	NULL
,	NULL
S.	NULL
P.	NULL
,	NULL
and	NULL
Cantley	NULL
,	NULL
L.	NULL
C.	NULL
(	NULL
1996	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

271	NULL
,	NULL
568-567	NULL
14	NULL
.	NULL

15	NULL
.	NULL

16	NULL
.	NULL

17	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

40	NULL
.	NULL

41	NULL
.	NULL

42	NULL
.	NULL

43	NULL
.	NULL

44.	NULL
.	NULL

Yoon	NULL
,	NULL
C.	NULL
H.	NULL
,	NULL
Lee	NULL
,	NULL
J.	NULL
,	NULL
Jongeward	NULL
,	NULL
G.	NULL
D.	NULL
,	NULL
and	NULL
Sternberg	NULL
,	NULL
P.	NULL
W.	NULL
(	NULL
1995	NULL
)	NULL
Science	NULL
269	NULL
,	NULL
173	NULL
REFERENCES	NULL
.	NULL

Langdon	NULL
,	NULL
W.	NULL
Y.	NULL
,	NULL
Hartley	NULL
,	NULL
J.	NULL
W.	NULL
,	NULL
Klinken	NULL
,	NULL
S.	NULL
P.	NULL
,	NULL
Ruscetti	NULL
,	NULL
S.	NULL
K.	NULL
,	NULL
and	NULL
Morse	NULL
,	NULL
H.	NULL
C.	NULL
(	NULL
1989	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

86	NULL
,	NULL
1168-1172	NULL
.	NULL

Blake	NULL
,	NULL
T.	NULL
J.	NULL
,	NULL
Shapiro	NULL
,	NULL
M.	NULL
,	NULL
Morse	NULL
,	NULL
H.	NULL
C.	NULL
,	NULL
and	NULL
Langdon	NULL
,	NULL
W.	NULL
Y	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Oncogene	NULL
6	NULL
,	NULL
653-657	NULL
.	NULL

Blake	NULL
,	NULL
T.	NULL
J.	NULL
,	NULL
and	NULL
Langdon	NULL
,	NULL
W.	NULL
Y	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Oncogene	NULL
7	NULL
,	NULL
757-762	NULL
.	NULL

Andoniou	NULL
,	NULL
C.	NULL
E.	NULL
,	NULL
Thien	NULL
,	NULL
C.	NULL
B.	NULL
,	NULL
and	NULL
Langdon	NULL
,	NULL
W.	NULL
Y	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

13	NULL
,	NULL
4515-4523	NULL
.	NULL

Fukazawa	NULL
,	NULL
T.	NULL
,	NULL
Reedquist	NULL
,	NULL
K.	NULL
A.	NULL
,	NULL
Trub	NULL
,	NULL
T.	NULL
,	NULL
Soltoff	NULL
,	NULL
S.	NULL
,	NULL
Panchamoorthy	NULL
,	NULL
G.	NULL
,	NULL
Druker	NULL
,	NULL
B.	NULL
,	NULL
Cantley	NULL
,	NULL
L.	NULL
,	NULL
Shoelson	NULL
,	NULL
S.	NULL
E.	NULL
,	NULL
and	NULL
Band	NULL
,	NULL
H.	NULL
(	NULL
1995	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270	NULL
,	NULL
19141-19150	NULL
.	NULL

Meisner	NULL
,	NULL
H.	NULL
,	NULL
Conway	NULL
,	NULL
B.	NULL
R.	NULL
,	NULL
Hartley	NULL
,	NULL
D.	NULL
,	NULL
and	NULL
Czech	NULL
,	NULL
M.	NULL
P.	NULL
(	NULL
1995	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

15	NULL
,	NULL
8571-8578	NULL
.	NULL

Odai	NULL
,	NULL
H.	NULL
,	NULL
Sasaki	NULL
,	NULL
K.	NULL
,	NULL
Iwamatsu	NULL
,	NULL
A.	NULL
,	NULL
Hanazono	NULL
,	NULL
Y.	NULL
,	NULL
Tanaka	NULL
,	NULL
T.	NULL
,	NULL
Mitani	NULL
,	NULL
K.	NULL
,	NULL
Yazaki	NULL
,	NULL
Y.	NULL
,	NULL
and	NULL
Hirai	NULL
,	NULL
H.	NULL
(	NULL
1995	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270	NULL
,	NULL
10800-10805	NULL
.	NULL

Panchamoorthy	NULL
,	NULL
G.	NULL
Fukazawa	NULL
,	NULL
T.	NULL
,	NULL
Miyake	NULL
,	NULL
S	NULL
,	NULL
,	NULL
Soltoff	NULL
,	NULL
S.	NULL
,	NULL
Reedquist	NULL
,	NULL
K.	NULL
,	NULL
Druker	NULL
,	NULL
B.	NULL
,	NULL
Shoelson	NULL
,	NULL
S.	NULL
,	NULL
Cantley	NULL
,	NULL
L.	NULL
,	NULL
and	NULL
Band	NULL
,	NULL
H.	NULL
(	NULL
1996	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

271	NULL
,	NULL
3187-3194	NULL
.	NULL

Rivero	NULL
,	NULL
L.	NULL
O.	NULL
,	NULL
Sameshima	NULL
,	NULL
J.	NULL
H.	NULL
,	NULL
Marcilla	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Robbins	NULL
,	NULL
K.	NULL
C.	NULL
(	NULL
1994	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

269	NULL
,	NULL
17363-17366	NULL
Bowtell	NULL
,	NULL
D.	NULL
D.	NULL
,	NULL
and	NULL
Langdon	NULL
,	NULL
W.	NULL
Y	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
Oncogene	NULL
11	NULL
,	NULL
1561-1567	NULL
Galisteo	NULL
,	NULL
M.	NULL
L.	NULL
,	NULL
Dikic	NULL
,	NULL
L.	NULL
,	NULL
Batzer	NULL
,	NULL
A.	NULL
G.	NULL
,	NULL
Langdon	NULL
,	NULL
W.	NULL
Y.	NULL
,	NULL
and	NULL
Schlessinger	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270	NULL
,	NULL
20242-20245	NULL
Meisner	NULL
,	NULL
H.	NULL
,	NULL
and	NULL
Czech	NULL
,	NULL
M.	NULL
P.	NULL
(	NULL
1995	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270	NULL
,	NULL
25332-25335	NULL
Tanaka	NULL
,	NULL
S.	NULL
,	NULL
Neff	NULL
,	NULL
L.	NULL
,	NULL
Baron	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
Levy	NULL
,	NULL
J	NULL
.	NULL

B	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270	NULL
,	NULL
14847-14851	NULL
Sasaki	NULL
,	NULL
K.	NULL
,	NULL
Odai	NULL
,	NULL
H.	NULL
,	NULL
Hanazono	NULL
,	NULL
Y.	NULL
,	NULL
Ueno	NULL
,	NULL
H.	NULL
,	NULL
Ogawa	NULL
,	NULL
S.	NULL
,	NULL
Langdon	NULL
,	NULL
W.	NULL
Y.	NULL
,	NULL
Tanaka	NULL
,	NULL
T.	NULL
,	NULL
Miyagawa	NULL
,	NULL
K.	NULL
,	NULL
Mitani	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
Yazaki	NULL
,	NULL
Y.	NULL
Biochem	NULL
.	NULL

Biophys	NULL
.	NULL

Res	NULL
.	NULL

Commun	NULL
.	NULL

216	NULL
,	NULL
838-847	NULL
Wang	NULL
,	NULL
Y.	NULL
,	NULL
Yeung	NULL
,	NULL
Y.	NULL
G.	NULL
,	NULL
Langdon	NULL
,	NULL
W.	NULL
Y.	NULL
,	NULL
and	NULL
Stanley	NULL
,	NULL
E.	NULL
R.	NULL
(	NULL
1996	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

271	NULL
,	NULL
17-20	NULL
Hartley	NULL
,	NULL
D.	NULL
,	NULL
Meisner	NULL
,	NULL
H.	NULL
,	NULL
and	NULL
Corvera	NULL
,	NULL
S.	NULL
(	NULL
1995	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270	NULL
,	NULL
18260-18263	NULL
.	NULL

Kim	NULL
,	NULL
T.	NULL
J.	NULL
,	NULL
Kim	NULL
,	NULL
Y.	NULL
T.	NULL
,	NULL
and	NULL
Pillai	NULL
,	NULL
S.	NULL
(	NULL
1995	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270	NULL
,	NULL
27504-27509	NULL
.	NULL

de	NULL
Jong	NULL
,	NULL
R.	NULL
,	NULL
ten	NULL
Hoeve	NULL
,	NULL
J.	NULL
,	NULL
Heisterkamp	NULL
,	NULL
N.	NULL
,	NULL
and	NULL
Groffen	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270	NULL
,	NULL
21468-21471	NULL
.	NULL

Ribon	NULL
,	NULL
V.	NULL
,	NULL
Hubbell	NULL
,	NULL
S.	NULL
,	NULL
Herrera	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
Saltiel	NULL
,	NULL
A.	NULL
R.	NULL
(	NULL
1996	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

16	NULL
,	NULL
45-52	NULL
.	NULL

Sawasdikosol	NULL
,	NULL
S.	NULL
,	NULL
Ravichandran	NULL
,	NULL
K.	NULL
S.	NULL
,	NULL
Lee	NULL
,	NULL
K.	NULL
K.	NULL
,	NULL
Chang	NULL
,	NULL
J.	NULL
H.	NULL
,	NULL
and	NULL
Burakoff	NULL
,	NULL
S.	NULL
J	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270	NULL
,	NULL
28983-2896	NULL
.	NULL

Liu	NULL
,	NULL
Y.-C.	NULL
,	NULL
Elly	NULL
,	NULL
C.	NULL
,	NULL
Bonnefoy-Bérard	NULL
,	NULL
N.	NULL
,	NULL
Yoshida	NULL
,	NULL
H.	NULL
,	NULL
and	NULL
Altman	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

271	NULL
,	NULL
14591-14595	NULL
.	NULL

Burbelo	NULL
,	NULL
P.	NULL
D.	NULL
,	NULL
and	NULL
Hall	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
Curr	NULL
.	NULL

Biol	NULL
.	NULL

5	NULL
,	NULL
95-96	NULL
.	NULL

Aitken	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
Trends	NULL
Biochem	NULL
.	NULL

Sci	NULL
.	NULL

20	NULL
,	NULL
95-97	NULL
.	NULL

Cory	NULL
,	NULL
G.	NULL
O.	NULL
,	NULL
Lovering	NULL
,	NULL
R.	NULL
C.	NULL
,	NULL
Hinshelwood	NULL
,	NULL
S.	NULL
,	NULL
MacCarthy	NULL
,	NULL
Morrogh	NULL
L.	NULL
,	NULL
Levinsky	NULL
,	NULL
R.	NULL
J.	NULL
,	NULL
and	NULL
Kinnon	NULL
,	NULL
C.	NULL
(	NULL
1995	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

182	NULL
,	NULL
611-615	NULL
.	NULL

Marcilla	NULL
,	NULL
A.	NULL
,	NULL
Rivero	NULL
,	NULL
L.	NULL
O.	NULL
,	NULL
Agarwal	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Robbins	NULL
,	NULL
K.	NULL
C.	NULL
(	NULL
1995	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270	NULL
,	NULL
9115-9120	NULL
.	NULL

Weiss	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Littman	NULL
,	NULL
D.	NULL
R.	NULL
(	NULL
1994	NULL
)	NULL
Cell	NULL
76	NULL
,	NULL
263-274	NULL
.	NULL

Mustelin	NULL
,	NULL
T.	NULL
(	NULL
1994	NULL
)	NULL
Immunity	NULL
1	NULL
,	NULL
351-356	NULL
.	NULL

Donovan	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
Wange	NULL
,	NULL
R.	NULL
L.	NULL
,	NULL
Langdon	NULL
,	NULL
W.	NULL
Y.	NULL
,	NULL
and	NULL
Samelson	NULL
,	NULL
L.	NULL
E.	NULL
(	NULL
1994	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

269	NULL
,	NULL
22921-22924	NULL
Fournel	NULL
,	NULL
M.	NULL
,	NULL
Davidson	NULL
,	NULL
D.	NULL
,	NULL
Weil	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
Veillette	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

183	NULL
,	NULL
301-306	NULL
Jain	NULL
,	NULL
J.	NULL
,	NULL
Loh	NULL
,	NULL
C.	NULL
,	NULL
and	NULL
Rao	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
Curr	NULL
.	NULL

Opin	NULL
.	NULL

Immunol	NULL
.	NULL

7	NULL
,	NULL
338-842	NULL
Crabtree	NULL
,	NULL
G.	NULL
R.	NULL
,	NULL
and	NULL
Clipstone	NULL
,	NULL
N.	NULL
A	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Annu	NULL
.	NULL

Rev	NULL
.	NULL

Biochem	NULL
.	NULL

63	NULL
,	NULL
1045-1083	NULL
Liu	NULL
,	NULL
Y.-C.	NULL
,	NULL
Kawagishi	NULL
,	NULL
M.	NULL
,	NULL
Mikayama	NULL
,	NULL
T.	NULL
,	NULL
Inagaki	NULL
,	NULL
Y.	NULL
,	NULL
Takeuchi	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Ohashi	NULL
,	NULL
H.	NULL
(	NULL
1993	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

90	NULL
,	NULL
8957-8961	NULL
Bonnefoy-Bérard	NULL
,	NULL
N.	NULL
,	NULL
Liu	NULL
,	NULL
Y.-C.	NULL
,	NULL
von	NULL
Willebrand	NULL
,	NULL
M.	NULL
,	NULL
Sung	NULL
,	NULL
A.	NULL
,	NULL
Elly	NULL
,	NULL
C.	NULL
,	NULL
Mustelin	NULL
,	NULL
T.	NULL
,	NULL
Yoshida	NULL
,	NULL
H.	NULL
,	NULL
Ishizaka	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
Altman	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

92	NULL
,	NULL
10142-10146	NULL
O'Keefe	NULL
,	NULL
S.	NULL
J.	NULL
,	NULL
Tamura	NULL
,	NULL
J.	NULL
,	NULL
Kincaid	NULL
,	NULL
R.	NULL
L.	NULL
,	NULL
Tocci	NULL
,	NULL
M.	NULL
J.	NULL
,	NULL
and	NULL
O'Neill	NULL
,	NULL
E.	NULL
A	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Nature	NULL
857	NULL
,	NULL
692-694	NULL
Clipstone	NULL
,	NULL
N.	NULL
A.	NULL
,	NULL
and	NULL
Crabtree	NULL
,	NULL
G.	NULL
R.	NULL
(	NULL
1992	NULL
)	NULL
Nature	NULL
857	NULL
,	NULL
695-697	NULL
Cai	NULL
,	NULL
Y.-C.	NULL
,	NULL
Cefai	NULL
,	NULL
D.	NULL
,	NULL
Schneider	NULL
,	NULL
H.	NULL
,	NULL
Raab	NULL
,	NULL
M.	NULL
,	NULL
Navavi	NULL
,	NULL
N.	NULL
,	NULL
and	NULL
Rudd	NULL
,	NULL
C.	NULL
E.	NULL
(	NULL
1995	NULL
)	NULL
Immunity	NULL
8	NULL
,	NULL
417-426	NULL
Ward	NULL
,	NULL
S.	NULL
G.	NULL
,	NULL
June	NULL
,	NULL
C.	NULL
H.	NULL
,	NULL
and	NULL
Olive	NULL
,	NULL
D.	NULL
(	NULL
1996	NULL
)	NULL
Immunol	NULL
.	NULL

Today	NULL
17	NULL
,	NULL
187-197	NULL
Songyang	NULL
,	NULL
Z.	NULL
,	NULL
Shoelson	NULL
,	NULL
S.	NULL
E.	NULL
,	NULL
Chaudhuri	NULL
,	NULL
M.	NULL
,	NULL
Gish	NULL
,	NULL
G.	NULL
,	NULL
Pawson	NULL
,	NULL
T.	NULL
,	NULL
Haser	NULL
,	NULL
W.	NULL
G	NULL
,	NULL
King	NULL
,	NULL
F.	NULL
,	NULL
Roberts	NULL
,	NULL
T.	NULL
,	NULL
Ratnofsky	NULL
,	NULL
S.	NULL
,	NULL
Lechleider	NULL
,	NULL
R.	NULL
J.	NULL
,	NULL
Neel	NULL
,	NULL
B.	NULL
G.	NULL
,	NULL
Birge	NULL
,	NULL
R.	NULL
B.	NULL
,	NULL
Fajardo	NULL
,	NULL
J.	NULL
E.	NULL
,	NULL
Chou	NULL
,	NULL
M.	NULL
M.	NULL
,	NULL
Hanafusa	NULL
,	NULL
H.	NULL
,	NULL
Schaffhausen	NULL
,	NULL
B.	NULL
,	NULL
and	NULL
Cantley	NULL
,	NULL
L.	NULL
C.	NULL
(	NULL
1998	NULL
)	NULL
Cell	NULL
72	NULL
,	NULL
767-778	NULL
Rayter	NULL
,	NULL
S.	NULL
I.	NULL
,	NULL
Woodrow	NULL
,	NULL
M.	NULL
,	NULL
Lucas	NULL
,	NULL
S.	NULL
C.	NULL
,	NULL
Cantrell	NULL
,	NULL
D.	NULL
A.	NULL
,	NULL
and	NULL
Downward	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

11	NULL
,	NULL
4549-4556	NULL
Woodrow	NULL
,	NULL
M.	NULL
,	NULL
Clipstone	NULL
,	NULL
N.	NULL
A.	NULL
,	NULL
and	NULL
Cantrell	NULL
,	NULL
D.	NULL
(	NULL
1998	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

178	NULL
,	NULL
1517-1522	NULL
Baldari	NULL
,	NULL
C.	NULL
T.	NULL
,	NULL
Heguy	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Telford	NULL
,	NULL
J.	NULL
L.	NULL
(	NULL
1998	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

268	NULL
,	NULL
8406-8409	NULL
Woodrow	NULL
,	NULL
M.	NULL
A.	NULL
,	NULL
Rayter	NULL
,	NULL
S.	NULL
,	NULL
Downward	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Cantrell	NULL
,	NULL
D.	NULL
A	NULL
.	NULL

(	NULL
1998	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

150	NULL
,	NULL
3858-3861	NULL
Mayer	NULL
,	NULL
B.	NULL
J.	NULL
,	NULL
and	NULL
Eck	NULL
,	NULL
M.	NULL
J	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
Curr	NULL
.	NULL

Biol	NULL
.	NULL

5	NULL
,	NULL
364-367	NULL
1102-1105	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
4g	NULL
/810-0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wo	NULL
;	NULL
popeoumog	NULL
Ras-dependent	NULL
,	NULL
Ca**-stimulated	NULL
Activation	NULL
of	NULL
Nuclear	NULL
Factor	NULL
of	NULL
Activated	NULL
T	NULL
Cells	NULL
by	NULL
a	NULL
Constitutively	NULL
Active	NULL
Chl	NULL
Mutant	NULL
in	NULL
T	NULL
Cells	NULL
Yun-Cai	NULL
Liu	NULL
,	NULL
Chris	NULL
Elly	NULL
,	NULL
Wallace	NULL
Y.	NULL
Langdon	NULL
and	NULL
Amnon	NULL
Altman	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

1997	NULL
,	NULL
272:168-173.	NULL
doi	NULL
:	NULL
10.1074/jb0.272.1.168	NULL
Access	NULL
the	NULL
most	NULL
updated	NULL
version	NULL
of	NULL
this	NULL
article	NULL
at	NULL
http	NULL
:	NULL
/www.jbe.org/content/272/1/168	NULL
Alerts	NULL
:	NULL
«	NULL
When	NULL
this	NULL
article	NULL
is	NULL
cited	NULL
«	NULL
When	NULL
a	NULL
correction	NULL
for	NULL
this	NULL
article	NULL
is	NULL
posted	NULL
Click	NULL
here	NULL
to	NULL
choose	NULL
from	NULL
all	NULL
of	NULL
JBC	NULL
's	NULL
e-mail	NULL
alerts	NULL
This	NULL
article	NULL
cites	NULL
44	NULL
references	NULL
,	NULL
27	NULL
of	NULL
which	NULL
can	NULL
be	NULL
accessed	NULL
free	NULL
at	NULL
http	NULL
:	NULL
//www	NULL
68	NULL
.full.html	NULL
#	NULL
ref-list-1	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
4g	NULL
wo	NULL
;	NULL
popeoumog	NULL

